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1. Executive Summary 
HIV overview 
Human Immunodeficiency Virus (HIV) is a virus that attacks the immune system using 
the body’s CD4 defence cells (white blood cells) to replicate. At the same time, HIV 
destroys these same cells that protect the body from illness. This results in a weakened 
immune system and can lead to people living with HIV (PLWH) becoming more 
susceptible to infections (World Health Organization – WHO, 2017). Higher CD4 
counts are associated with improved outcomes. Acquired Immunodeficiency Syndrome 
(AIDS) is the most advanced stage of HIV infection. AIDS describes a set of symptoms 
and illnesses that happen at the final stage of HIV infection when the immune system 
has been significantly weakened. 
HIV can either be transmitted through unprotected sexual contact, sharing intravenous 
drug equipment, mother to child transmission during pregnancy, birth or breast-milk, or 
through contaminated blood transfusions (AIDS.gov, 2015). Whilst there is currently no 
cure for HIV, treatment consists of Antiretroviral Therapy (ART) which fights HIV by 
interfering with the reproduction of the virus in the body (WHO, 2017). HIV remains a 
major public health concern. In 2018, 37.9 million people globally were living with 
HIV with 1.8 million people newly diagnosed with HIV in that year (United Nations 
AIDS – UNAIDS, 2018). In 2017, 102,000 people were living with HIV in the UK with 
4,363 people were newly diagnosed with HIV (Public Health England - PHE, 2018a). In 
2019, The UK government set out a commitment to eliminate transmission of HIV in 
England by 2030 (Department of Health and Social Care - DHSC, 2019). 
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Systematic review 
Over half the clinical events and deaths occurring among those on ART are “non-AIDS 
defining” (Palella et al., 2006). AIDS-defining refers to illnesses attributable to the 26 
serious and life-threatening diseases (Centers for Disease Control and Prevention – 
CDC; Ward, Buehler, Jaffe, & Berkelman, 1992) that occur in PLWH with the 
advanced stage of HIV infection (i.e., Acquired Immunodeficiency Syndrome – AIDS). 
The most common chronic physical health comorbidities in PLWH include non-
communicable diseases such as diabetes mellitus, cardiovascular disease, chronic 
obstructive pulmonary diseases (e.g., Crothers et al., 2006, Sudano et al., 2006); and 
communicable diseases such as hepatitis (Turner et al., 2010) and tuberculosis (TB; 
Bruchfeld, Correia-Neves & Källenius, 2015). 
 
Different comorbid physical health conditions in PLWH are often linked to HIV 
infection and its associated risk factors, including adverse effects of certain 
antiretroviral medication (Goulet et al., 2007). These risk factors can negatively affect 
health outcomes. In addition, economic and social conditions can influence individual 
and group differences in health status (Marmot & Wilkinson, 2005) and can mean that 
individuals with comorbid chronic physical health conditions are more vulnerable to 
poorer health outcomes. Managing the psychological challenges of living with HIV 
alongside comorbid physical health conditions can be difficult.  
 
The aim of the systematic review was to consider the experiences of those living with 
HIV and comorbid physical health conditions. A systematic synthesis of the relevant 
qualitative literature aimed to help provide an improved understanding of the current 
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evidence base, and inform the design of new interventions/strategies to help support 
individuals with HIV and comorbid health conditions; and allow for identification of 
existing research gaps. 
 
Inclusion criteria comprised HIV-positive individuals ≥ 18 years with common physical 
and chronic/difficult to treat/incurable comorbid health conditions. Only qualitative 
studies were eligible. Studies in peer-reviewed journals were retrieved from Scopus, 
PsycINFO, PubMed, and the Networked Digital Library of Theses and Dissertations 
and search terms were searched for as key words in titles and abstracts. The author 
carried out the searches and both the author and a second reviewer independently 
assessed the eligibility of retrieved articles. Details including authors, date of 
publication, location, HIV-status, design, nature of sample, age, gender, ethnicity, 
country of origin, findings of psychological outcomes and themes were extracted. The 
methodological quality of the studies was evaluated using criteria for a qualitative 
design and was carried out independently by the author and a second reviewer. A 
narrative synthesis approach was used to identify and understand key findings from the 
included studies (Popay et al., 2006). Disagreements were resolved by a third reviewer 
for eligibility and quality. 
 
Twenty-two studies were included in the analysis. Studies were published between 2007 
and 2018. Seven studies were conducted in South Africa; six in the USA; two in 
Ethiopia; two in India; one in Ghana; one in Zambia; one in Ireland; one in Canada; and 
one in the UK. For qualitative studies, 13 findings were extracted and grouped into five 
categories – Management of HIV and comorbid physical health conditions, 
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Psychological outcomes of HIV and comorbid physical health conditions, Preferences 
for care, Stigma, and Disclosure. Quotes from the texts were compiled to illustrate these 
findings. Two studies met all the quality appraisal criteria. 
 
The findings are similar to previous research which has explored difficulties 
surrounding management of HIV and physical health conditions, HIV-disclosure, the 
presence of HIV-stigma and psychological outcomes in various HIV-positive 
populations. Limitations included the search strategy where key terms were only 
searched for in titles and abstracts. A strength of the review process was the 
independent reviewing of eligible studies and study quality by independent reviewers. 
The systematic review suggests that experiences of living with HIV and comorbid 
physical health conditions interact and can have a negative impact on mental health. 
Further research into the anticipated and experienced HIV-stigma that individuals living 
with HIV and comorbid physical health conditions face would aid understanding of how 
stigma related to HIV and other physical health conditions emerge in this population.   
 
Empirical project 
Tuberculosis (TB) is an infectious disease and the leading preventable cause of death 
worldwide for people living with Human Immunodeficiency Virus (HIV).  TB usually 
impacts the lungs, but TB-causing bacteria can attack any part of the body. An 
individual’s immune system can respond to TB in a variety of ways: the bacteria may be 
cleared, the individual may develop active TB and become unwell, or the bacteria may 
remain as latent TB infection (LTBI). TB treatment typically entails taking antibiotics 
over several months. 
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In the last two decades, TB has re-emerged in the UK, linked to HIV infection and 
migratory phenomenon (Lönnroth et al., 2015). In 2018, there were 10 million new 
cases of TB worldwide (WHO, 2018), with 5,102 UK cases in 2017 (WHO, 2018). In 
England, the prevalence of HIV co-infection among TB patients is between 5-9% 
(Kruijshaar et al., 2010), with 80.1% of HIV/TB co-infected individuals being non-UK 
born (PHE, 2018b). Experiences of being a migrant may complicate adjustment to 
HIV/TB co-infection including immigration status, acculturation (i.e., the adoption of 
the values and behaviours of the surrounding culture) and discrimination (Bhugra, 
2004). Prior findings from low income settings cannot be generalised to UK migrants as 
there are differences in socio-medical contexts. No research has focused on adjustment 
for migrants with HIV/TB co-infection in high income countries. 
 
HIV and TB pose a number of adjustment challenges. Similarities and differences exist 
between HIV and TB: TB is curable, whereas HIV is not; both conditions are infectious 
with potential public health risks, but with different transmission routes; treatment for 
active TB can be more complicated and prone to side effects than HIV; both can remain 
latent/undetected for many years and require monitoring one’s health to limit negative 
health effects (WHO, 2012).  
 
A qualitative Grounded Theory design was used. Semi-structured interviews were 
carried out with nine migrants living in the UK (six males, three females, aged 33 – 63 
years, mean time in the UK = 11 years, five participants from Sub-Saharan Africa, two 
from Europe, one from South Asia and another from South-east Asia. Ethics was 
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obtained from an NHS ethics committee and Royal Holloway’s ethics committee. 
Participants were recruited via two HIV-services across London. Inclusion criteria 
included foreign born, with adequate spoken English, who received an HIV-positive test 
in the last three months onwards; and TB diagnosis in the last three months to five 
years. Participants were only excluded if there was any evidence of significant risk of 
harm to self or others. Participants were given the Hospital Anxiety and Depression 
Scale to provide some context to the sample. Participants were paid £10 for their 
participation in the research. 
 
The interviews were transcribed, coded and seven theoretical codes were identified; 
Migrating to the UK, Ideas of HIV and TB prior to receiving diagnoses, Accessing 
healthcare up to the point of receiving HIV and TB diagnoses, Experiences whilst 
accessing specialist HIV and TB care, Managing Disclosure of HIV and TB, Managing 
mental health after receiving HIV and TB diagnoses, Appraisal and coping with HIV 
and TB. A theoretical model individual and social processes of living with HIV/TB co-
infection in UK migrants was developed outlining how the codes interact.  
 
The findings are similar to previous research in HIV populations which has found high-
levels of HIV-stigma and HIV-disclosure anxiety. TB was disclosed more frequently by 
participants compared to HIV and this was linked to beliefs about it being curable. 
Services could run audits to identify reasons for high levels of stigma and provide 
interventions to attenuate this. There appeared to have been delays to testing for HIV 
and TB that were both patient and health system related. Risk perception for HIV and 
TB was low amongst participants, and there were missed opportunities for HIV and TB 
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testing by healthcare professionals. Reflective groups facilitated by Clinical 
Psychologists could be promoted to support healthcare professionals to raise issues 
around this including identifying any difficulties adhering to National Institute for 
Health and Care Excellence - NICE, and British HIV Association - BHIVA guidelines 
around routine testing for HIV and testing for TB where relevant symptoms exist. 
Participants’ experiences of healthcare professionals in specialist services were positive. 
In particular, many appreciated being provided with information regarding medication 
alongside health-related progress updates and this appeared to help improve coping. 
 
Integration, impact and dissemination 
The systematic review and the empirical piece guided and informed each other 
throughout each research stage. Both the systematic review and the empirical piece 
focused on the lived experiences of HIV positive individuals with comorbid physical 
health conditions. The systematic review focused on illness experiences; and the 
empirical piece focused on the social and individual processes of living with HIV and 
TB co-infection. Relevant factors included HIV and comorbid physical health condition 
stigma processes, disclosure, and coping/adjustment, in addition to managing mental 
health difficulties. Participants in the systematic review were located in low- and high-
income countries. Participants in the empirical piece were from the UK which is a high-
income setting. The age of participants varied: participants in the empirical piece aged 
from 33 to 63 years; whilst participants in the systematic review had a larger age range 
from 18 to 69 years of age.  
The systematic review and the empirical piece found themes relating to HIV and 
comorbid physical health condition stigma, HIV and TB-related distress and the 
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negative impact HIV and TB diagnoses can have on anxiety and mood. They both also 
found themes relating to disclosure decisions, and include examples of participants’ 
decisions to share or not share with others their HIV and comorbid health condition 
statuses. Issues of coping and living with HIV and comorbid physical health conditions 
were also found in the systemic review and empirical piece alongside examples of 
positive adjustment and adjustment difficulties. 
At all stages of conducting research, the researcher attempted to remain aware of 
differences between herself and participants (visible and invisible) and the degree to 
which she was located inside or outside the group being researched. She reflected on 
how her status within this space may shape and impact the research process and its 
outcomes. 
 
The findings of the research have the potential to impact migrants living with HIV/TB 
co-infection, their friends and family, General practitioners (GPs) and other healthcare 
professionals working in the HIV and TB field. Other potential beneficiaries include 
faith leaders, organisations supporting migrants with HIV and TB, academics such as 
HIV and TB researchers, and HIV and TB policy makers (e.g. BHIVA, World Health 
Organization - WHO). The research could help increase the confidence and hope of 
people living with HIV and TB and increase knowledge and confidence of healthcare 
professionals and other agencies in how best to support migrants living with HIV/TB 
co-infection in a high-income setting. 
 
Findings could be disseminated to key stakeholders, and teaching and training provided 
for GPs and other healthcare professionals. To help promote the potential impact of this 
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research, working groups with all involved agencies could be developed. In addition, 
the findings could help inform a social media campaign focused on encouraging early 
access to health services and challenging any stigmatising views about HIV and TB. 
Findings of the research (i.e., lay language summaries) will be provided to participants. 
In addition, to support others working in the field the findings will be presented to the 
HIV-service recruitment sites, and submitted to an academic journal alongside HIV-
related conferences. 
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2. What are the experiences of people living with HIV and 
comorbid physical health conditions? A qualitative systematic 
review 
Abstract  
HIV is a virus that impairs the immune system via various transmission routes. Access 
to antiretroviral therapy (ART) has made it possible for people living with HIV 
(PLWH) to achieve longer, healthier lives. Along with increased life expectancy comes 
an increased burden of comorbid physical health conditions. Over half the clinical 
events and deaths occurring among those on ART are “non-AIDS defining” (Palella et 
al., 2006). Following an HIV diagnosis, a number of potential stressors exist relating to 
the diagnosis experience itself, the need to adhere to treatment, fear of death, HIV 
disclosure decisions, changes to intimate and non-intimate relationships and interactions 
within a complex medical system. For PLWH and comorbid physical health conditions, 
managing multiple conditions may compound these stressors. Consequently, a number 
of psychological factors are likely to be associated with navigating these potential 
challenges. Understanding these challenges is crucial to support this group of 
individuals. This systematic review considered the lived experiences of individuals with 
HIV and comorbid physical health conditions. 
Articles were retrieved from Scopus, PsycINFO, PubMed and the Networked Digital 
Library of Theses and Dissertations. Their eligibility and quality were appraised by two 
independent raters and disagreements were resolved by a third rater. Twenty-two 
qualitative studies were eligible for inclusion in the review. A data synthesis was 
conducted.  
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The findings are similar to previous research which has explored difficulties 
surrounding management of HIV and comorbid physical health conditions, HIV-
disclosure, the presence of HIV-stigma and consequent mental health problems in 
various HIV-positive populations. 
Two studies met the full methodological appraisal criteria. Research and practice 
implications are discussed, with emphasis on the need for future research into the 
anticipated and experienced HIV- stigma that individuals living with HIV and comorbid 
physical health conditions face. This would aid understanding of how stigma related to 
HIV and other physical health conditions emerge in this population.   
Introduction 
HIV and comorbid physical health conditions 
HIV is a virus that impairs the immune system via various transmission routes (see 
Executive Summary for further details on HIV; p.7). Access to antiretroviral therapy 
(ART) has made it possible for PLWH to achieve longer, healthier lives (National 
Institutes of Health - NIH.gov, 2019). Along with increased life expectancy comes an 
increased burden of comorbid physical health conditions (WHO, 2014). Over half the 
clinical events and deaths occurring among those on ART are “non-AIDS defining” 
(Palella et al., 2006). AIDS defining refers to illnesses attributable to the 26 serious and 
life-threatening diseases (CDC – Ward et al., 1992) that occur in PLWH with the 
advanced stage of HIV infection (i.e., Acquired immunodeficiency syndrome – AIDS). 
The most common chronic physical health comorbidities in PLWH include non-
communicable diseases such as diabetes mellitus, cardiovascular disease, chronic 
obstructive pulmonary diseases (e.g., Crothers et al., 2006, Sudano et al., 2006); and 
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communicable diseases such as hepatitis (Turner et al., 2010) and tuberculosis (TB; 
Bruchfeld et al., 2015). 
 
Comorbid physical health conditions in PLWH may be pre-existing or linked to ageing, 
but are often due to HIV infection and its associated risk factors including adverse 
effects of certain antiretroviral medication (Goulet et al., 2007). Health outcomes can be 
impacted by these risk factors and inequalities. The social determinants of health (SDH) 
such as psychosocial factors, socioeconomic circumstances, neighbourhood 
environment and political, economic and cultural drivers (Marmot & Wilkinson, 2005) 
can render people with comorbid chronic physical health conditions more vulnerable to 
poorer health outcomes. These individuals often need to engage more regularly with the 
broader health system beyond specialized HIV clinics to obtain the care they need 
(Narayan et al., 2014; Nigatu, Oldenburg, Elliott, Setswe & Woldegiorgis, 2013).  
Managing the psychological challenges of living with HIV alongside comorbid physical 
health conditions can be difficult. 
Psychological factors 
Following an HIV diagnosis a number of potential stressors exist relating to the 
diagnosis experience itself, the need to adhere to treatment, fear of death, HIV 
disclosure decisions, changes to intimate and non-intimate relationships and interactions 
within a complex medical system. For PLWH and comorbid physical health conditions, 
managing multiple conditions may compound these stressors. Consequently, a number 
of psychological factors are associated with navigating these potential challenges. 
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Stigma 
Stigma has been conceptualised as a socially ‘devalued attribute’ which in turn affects 
the way people react to knowledge they do or do not possess the devalued attribute. 
HIV has been offered as an example of such an attribute (Earnshaw & Chaudoir, 2009). 
Previous research with individuals with HIV has identified three forms of stigma: 
internalised (i.e. degree of shame/self-loathing felt); enacted (i.e., past experiences of 
discrimination); and anticipated (i.e. expectations of being the target of social 
rejection/discrimination) (Earnshaw, Smith, Chaudoir, Amico & Copenhaver, 2013). It 
can be useful to think about these separate processes of stigma and their potential 
impact on adjustment. Stigma can lead people living with HIV to face social exclusion, 
that is, being denied full access to various rights, opportunities and resources to which 
other members of a different group (i.e., HIV uninfected) have access (Earnshaw & 
Chaudoir, 2009). Research has shown that PLWH are routinely discriminated against 
and excluded within their communities (Mbonu, van den Borne, & De Vries, 2009). 
Research with PLWH has also found that a variety of additional stigmatized identities 
(e.g., mental illness, sexual orientation) result in a greater social burden of illness, 
impacting on maintaining psychological health (Chaudoir, Fisher, & Simoni, 2011).  
 
Individuals with HIV and comorbid physical health conditions can face increased levels 
of stigma. For example, PLWH and TB face stigma related to both conditions (Daftary, 
2012), impacting on disclosure decisions for both conditions. This group also faces a 
lack of support, poverty and feelings of hopelessness and helplessness, resulting in 
complex challenges to ART adherence (Gebrekristos, Lurie, Mthethwa, & Karim, 2009; 
Gebremariam, Bjune, & Frich, 2010; Naidoo, Dick, & Cooper, 2009). TB is a 
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communicable disease with public health risks, and is curable with treatment, whereas 
other comorbid physical health conditions may not be so. It is unclear to what extent 
findings can be attributed to other conditions such as diabetes mellitus and 
cardiovascular disease which are non-communicable and require on-going treatment. 
Coping  
Coping is defined as thoughts and behaviours that people use to manage the internal and 
external demands of situations that are appraised as stressful (Lazarus & Folkman, 
1984). Studies have revealed that people living with HIV use a variety of coping 
strategies, such as distraction, social support, religion, acceptance, and direct action 
(i.e., taking active steps to address the stressor and its effects) (Burchardt, 2010; 
Deichert, Fekete, Boarts, Druley, & Delahanty, 2008; Hodge & Roby, 2010). In people 
without HIV who are living with long-term conditions such as diabetes, social support 
has been linked to improved coping and treatment adherence (Gallant, 2003; 
Ramkisson, Pillay & Sibanda, 2017), alongside higher levels of quality of life (Tang, 
Brown, Funnell & Anderson, 2008). Individuals with limited social support who are 
living with both HIV and a comorbid physical health condition may find it more 
challenging to cope and maintain a good quality of life without friends or relatives 
supporting them. 
Mental health 
Mental health refers to “a state of well-being in which every individual realizes his or 
her own potential, can cope with the normal stresses of life, can work productively and 
fruitfully, and is able to make a contribution to her or his community.” (WHO, 2014). 
Wellbeing refers to “diverse and interconnected dimensions of physical, mental, and 
social wellbeing that extend beyond the traditional definition of health. It includes 
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choices and activities aimed at achieving physical vitality, mental clarity, social 
satisfaction, a sense of accomplishment, and personal fulfilment” (Naci & Ioannidis, 
2015, p121). For PLWH, poor mental health status can serve as a barrier to adequate 
ART adherence, and consequently decrease quality of life and increase mortality 
(Brandt, 2009; Clucas, Sibley, Harding, Liu, Catalan & Sherr, 2011; Sherr, Clucas, 
Harding, Sibley & Catalan, 2011). For individuals without HIV who have 
cardiovascular disease (Sin, 2016), lower levels of positive wellbeing have been found 
to be associated with increased stress reactivity and poorer coping skills. 
 
Living with HIV is challenging, and anxiety and mood disorders, particularly 
depression, are the most common psychiatric diagnoses (Edmiston, Passmore, Smith, & 
Petoumenos, 2015; Kendall et al., 2014). In terms of HIV disease progression, having 
depression can significantly increase plasma viral load—even after effective ART is 
initiated (Ironson et al., 2005) – and accelerate the decline of CD4 cell counts (white 
blood cells that are an essential part of the human immune system). Given the evidence 
base on the effects that depression can have on HIV-related issues, it is important to 
gain a better understanding of the illness experiences of PLWH and comorbid physical 
health conditions. 
Theories of adjustment and coping 
Adjustment to HIV diagnosis can be both complex and difficult. The Transactional 
Theory of Stress and Coping (Lazarus & Folkman, 1984) proposes that coping is part of 
a response to situations appraised as stressful. Many theories around adjustment relate 
to appraisal, that is, individuals' evaluations of the significance of the impact of an event 
on their wellbeing, and coping (Lazarus, 1993). The Transactional Theory of Stress and 
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Coping proposes two forms of appraisal: (1) Primary appraisal concerns the individual’s 
appraisal of the stressors and the coping strategies they use for managing these 
stressors; (2) secondary appraisal concerns the assessment of whether they can cope 
with the possible benefits or threats. A meta-analysis (Moskowitz, Hult, Bussolari & 
Acree, 2009) of types of coping that related to psychological wellbeing in people with 
HIV found that “direct action” (e.g. finding a healthcare provider”) and “positive re-
appraisal” (e.g., I have learned something from this experience”) were associated with 
better outcomes for people coping with HIV. Social support has also been cited as 
providing an important influence in moderating adjustment and coping to an HIV 
diagnosis (McDowell & Serovich, 2007; Peterson, Folkman & Bakeman, 1996; Schmitz 
& Crystal, 2000). 
 
Moss-Morris’ (2013) ‘unified’ model of adjustment cites multiple causal factors for 
poor adjustment that are relevant to individuals with HIV and comorbid physical health 
conditions. These factors include a change in identity and life roles, lower levels of 
social support and socio-economic status, difficult treatment regimens and an uncertain 
future. Good adjustment is proposed to be represented by less distress, less impact on 
identity, life roles, and relationships, good illness management and positive affect. This 
model highlights that individuals can be in adjustment equilibrium and disequilibrium at 
different times. As already outlined, it is likely that many aspects of living with HIV or 
chronic health conditions could be perceived as stressful and likely to be exacerbated in 
PLWH and comorbid physical health conditions. 
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The Common Sense Model (CSM; Leventhal, Meyer & Nerenz (1980) proposes that 
illness perceptions directly influence coping strategies, which then influence outcomes. 
Perceptions are conceptualised as lay interpretations of information and personal 
experiences that the individual has acquired. These are proposed to include five main 
cognitive domains: 1) identity (label and symptoms), 2) timeline, 3) consequences, 4) 
cause, and 5) perceived controllability/curability. In addition, a non-cognitive domain of 
emotional perceptions is included. The model proposes parallel processing of cognitions 
and emotions. 
Barriers to managing HIV and comorbid physical health conditions 
Managing beliefs and feelings linked to having HIV and comorbid physical health 
conditions can be compounded by the difficult social and economic circumstances faced 
by this group. Across and within countries worldwide, there is evidence that a social 
gradient in health exists where the lower an individual’s socioeconomic position, the 
worse their health outcomes (WHO, 2014). Unemployment, poor education levels, lack 
of accessible quality healthcare and lack of basic sanitation and housing (Gilbert & 
Walker, 2002; Kasese-Hara, Mayekiso, Modipa, Mzobe, & Mango, 2008; Van Niekerk, 
2001) can affect the wellbeing of PLWH. For those in high income countries, many 
living with HIV are migrants and can experience the pressure of finding an income and 
precarious housing, which can impede their ability to take care of their health and attend 
appointments regularly. Food insecurity can contribute to poor nutrition and impact 
mental and physical health, increasing the risk of developing comorbid conditions 
(Feldman, Alexy, Thomas, Gambone, & Irvine, 2015; Palar et al., 2015). Stigma 
relating to ethnicity, race, migrant status, class, age, gender and sexuality combined 
with HIV-stigma can further disadvantage whose who occupy devalued statuses. In 
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addition, for migrants to high income countries, changes in medical context, with 
greater medication availability, differences in integrated care and limited social support 
may impact on adjustment positively and negatively. 
 
From the research reviewed, it is likely that the consequences of living with HIV and 
comorbid physical health conditions will impact on wellbeing and mental health. These 
consequences could be an additional barrier in how this population manages living with 
multiple conditions. There is currently little information about the illness experiences of 
PLWH and a range of comorbid physical health conditions, therefore it is important to 
know more about the experiences of this population. 
Aims of the systematic review 
This is the first review that the author is aware of to consider the illness experiences of 
PLWH and comorbid chronic physical health conditions globally. A systematic 
synthesis of the relevant qualitative literature will help to provide an improved 
understanding of the current evidence base, and could inform the design of new 
interventions/strategies. This could in turn help support individuals with HIV and 
comorbid physical health conditions and allow for identification of existing research 
gaps. Any findings of this review may have implications for health services generally, 
in particular mental health services. Findings might also help guide healthcare 
professionals working with individuals with HIV and comorbid health conditions, and 
help update and/or reinforce existing guidelines for managing HIV with other 
conditions worldwide (e.g., British HIV Association – BHIVA – Standards of care for 
people living with HIV, 2018). Previous reviews of illness experiences and 
psychological factors have often focused singly on the illness experiences of those with 
25 
 
 
 
HIV or other physical health conditions. This review adopts a globally inclusive 
approach, as no prior reviews in low, middle- or high-income countries have been 
undertaken on the illness experiences of PLWH and a range of comorbid physical health 
conditions, to the author’s knowledge.  
Method 
Study eligibility 
Inclusion criteria were articles that report the experiences of adults (≥ 18 years) with 
HIV and any co-morbid health condition, including infectious and non-infectious 
diseases that were:  
- Physical (causation and primary effects) 
- Chronic/difficult to treat/incurable 
- Non-AIDS defining (see Executive Summary for p.8 for a definition) 
- Common (i.e., those that met the above criteria and are either on the WHO 
classification system for HIV infection, Stages 1 – 3, 2016. That is, not the 
AIDS defining illnesses attributable to the 26 serious and life-threatening 
diseases (CDC – Ward et al., 1992) that occur in PLWH with the advanced stage 
of HIV infection; the top 10 most common cancers worldwide, from 
GLOBOCAN (Global Burden of Cancer Study) estimates of incidence and 
mortality worldwide for cancers (Bray et al., 2018); the WHO top 10 global 
causes of death, (WHO, 2018); or the top 10 leading causes of disability – from 
the Global Burden of Disease Study (Wang et al., 2017). 
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Qualitative or mixed method study designs were included where qualitative results were 
reported separately. Studies that only report quantitative results were excluded. Studies 
were included from countries of all income levels. 
Sources of information 
Studies in peer-reviewed journals were retrieved from Scopus, PsycINFO, PubMed and 
the Networked Digital Library of Theses and Dissertations and citations on 10th October 
2018. Following screening to help find articles that may have been missed by database 
searches, reference lists of relevant primary research articles were examined in addition 
to articles where these have been cited. Searches were restricted to studies conducted 
since 1 January 1996 due to effective antiretroviral medication becoming available from 
this time. 
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Search strategy 
Searches were conducted using combinations of the following search terms: 
Table 1: Systematic review concepts and search terms 
Concept Search Term 
HIV HIV OR 
“Human Immunodeficiency Virus” OR 
AIDS OR 
“Acquired Immunodeficiency Syndrome” 
 
Comorbidity Comorbid* OR 
Co-morbid* OR 
Multimorbid* OR 
Multi-morbid* OR 
Coinfection* OR 
Co-infection* OR 
“Dual diagnosis” 
 
Illnesses Tuberculosis OR 
TB OR 
 
Herpes OR 
Hepatitis OR 
 
“Cardiovascular disease” OR 
CVD OR 
“Heart disease” OR 
“Coronary artery disease” OR 
CAD OR 
“Ischaemic heart disease” OR 
IHD OR 
Hypertension OR 
Diabetes OR 
Stroke OR 
“Multiple Sclerosis” OR 
 “Back pain” 
 
“Chronic obstructive pulmonary disease” OR 
COPD OR 
"Trachea cancer" OR 
"Bronchus cancer" OR 
 "Lung cancer" OR 
“Oesophag* cancer” OR 
 “Thyroid cancer” OR 
 
"Breast cancer" OR 
“Cervical cancer” OR 
“Bladder cancer” OR 
"Colon cancer" OR 
"Rect* cancer" OR 
“Colorectal cancer” OR 
“Prostate cancer” OR 
“Stomach cancer” OR 
 “Liver cancer” OR 
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Concept Search Term 
 
“Kidney disease” OR 
“Renal disease” 
 
Views/experience: View* OR 
Experience* OR 
Knowledge OR 
Opinion* OR 
Understand* OR 
Concern* OR 
Perception* OR 
Perspectiv* OR  
Cognition*  OR   
Feeling*  OR   
Preference*  OR   
Decision* OR 
Attitude* OR 
Belief* 
 
Qualitative: Interview* OR 
Qualitative OR 
"Group discussion*" OR 
"Focus group*" OR 
"Grounded Theor*" OR 
Phenomenolog* OR 
"Action research" OR 
Ethnograph* OR   
Questionnaire*  OR  
Anthropolog*  OR 
Self-report*  OR  
"Self report*" OR   
"Thematic analys*"  OR   
Narrative*  OR  
 IPA OR   
"Interpretative Phenomenological Analysis” OR 
Survey* 
 
Data collection 
The Centre of Reviews and Dissemination (CRD) guidance for conducting systematic 
reviews was followed. The search strategy used to identify and screen for relevant 
articles was informed by PRISMA (Preferred Reporting Items for Systematic Reviews 
and Meta-Analyses guidelines; Moher, Liberati, Tetzlaff, Altman, 2009; See Figure 1). 
• Identification: The author carried out the search for the identification of studies, 
using the pre-specified search criteria outlined above. To help find articles that 
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may have been missed by database searches, reference lists of relevant primary 
research articles were examined in addition to articles where these have been 
cited. All duplications between databases were removed. 
• Screening: Titles and abstracts were independently screened for eligibility by 
two reviewers (the author and an undergraduate psychology student). Articles 
considered relevant by either reviewer were retrieved in full text. 
• Eligibility: Both reviewers independently assessed the eligibility of the retrieved 
articles. Exclusions were recorded in an Excel spreadsheet, with reasons given 
and kappa was calculated Any disagreements were resolved by a third reviewer 
(the internal supervisor) to result in a final group of studies for analysis.  
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Figure 1. PRISMA flow diagram of the search eligibility process 
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Data abstraction 
The following details were extracted from the articles: authors, date of publication, 
location, HIV status, comorbidity status, design, nature of sample, age, gender, 
ethnicity, country of origin, analytic method, and reported themes. 
Quality assessment 
The methodological quality of the studies was evaluated using criteria for qualitative 
designs. The quality criteria (see Table 2) were based on an adapted version of the 
Mixed Methods Appraisal Tool’s (MMAT – Pluye et al., 2011) qualitative studies 
criteria. Two reviewers (the author and an undergraduate psychology student) assessed 
all included papers independently before comparing ratings. Any disagreements were 
resolved by the third reviewer (internal supervisor). The MMAT was adapted with 
criteria prioritised to help minimise the chance of articles being rejected despite 
appearing to substantively answer the MMAT questions. This was also completed to 
allow the MMAT to be operationalised in a way that supported the author and the 
undergraduate reviewer to use it. 
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Table 2. MMAT Qualitative study methodology assessment guide (adapted) 
1. Are the sources of qualitative data (archives, 
documents, informants, observations) relevant 
to address the research question? 
 
Consider: 
(a) Are the sample inclusion/exclusion criteria and 
the sampling method clearly described and relevant 
to address the research question?  
(b) Are explanations given for why certain potential 
participants chose not to participate?  
If at least (a) is present, then choose YES. 
 
  
2. Is the process for analyzing qualitative data 
relevant to address the research question? 
Consider: 
(a) Is the data collection method clear (e.g. in depth 
interviews and/or group interviews, and/or 
observations and/or documentary sources)?  
(b) Is it clear what form of data was collected? (e.g. 
tape recording, video material, and/or field notes)  
(c) Have any changes made to methods been 
explained?  
(d) Does the qualitative data analysis address the 
research question? (e.g. Ethnography, 
Phenomenology, Narrative, Grounded theory, Case 
Study, Qualitative Description. 
If at least (a) and (d) are present, then choose 
YES. 
  
3. Is appropriate consideration given to how 
findings relate to the context, e.g., the setting, in 
which the data were collected? 
 
Consider: 
(a) Is the setting described clearly (e.g. region of 
country, urban/rural area, area of high 
unemployment)?  
(b) Are the similarities and differences between the 
study setting and other settings of the same type 
noted?   
If at least (a) is present, then choose YES. 
  
4. Is appropriate consideration given to how 
findings relate to researchers’ influence, e.g., 
through their interactions with participants? 
Consider: 
(a) Is there a description of how findings relate to 
researchers' perspectives, roles and interactions 
with participants (“e.g. Identification of their 
disciplinary affiliation, what brought them to the 
question, and the assumptions they make about the 
topic of interest”)?   
(b) Is the researcher’s role influential at all stages 
(formulation of a research question, data collection, 
data analysis and interpretation of findings)  
(c) Do researchers explain their reaction to critical 
events that occurred during the study?   
If at least (a) is present, then choose YES. 
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Analysis 
Inter-rater reliability was assessed using Cohen’s Kappa = 0.47, indicating a moderate 
level of agreement between the reviewers.  
Qualitative study findings were analysed. A narrative synthesis approach was used to 
identify and understand key findings from the included studies (Popay et al., 2006). 
This process involved data extraction, evaluation and synthesis of findings across 
studies. To conduct the synthesis the author read and reread articles to identify emergent 
themes from each study. Themes that related to each other across studies were grouped 
together to develop categories by the author, verified by the internal supervisor, and a 
table was provided (see Table 4). 
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Results 
Of the 937 studies identified through the initial search, 22 met inclusion criteria for 
review (see PRISMA flow diagram, Methodology section - Figure 1). 
Overall study characteristics 
Studies were published between 2007 and 2018. Seven studies were conducted in South 
Africa; six in the USA; two in Ethiopia; two in India; one in Ghana; one in Zambia; one 
in Ireland; one in Canada; and one in the UK. For further study characteristics and 
details on methodology and the sample please see Table 3 - Qualitative studies 
proforma.
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Table 3. Qualitative studies proforma 
Reference Location and Population Methodology and Sample Themes 
Amutah-
Onukagha et al. 
(2018) 
 
 
USA 
African American substance 
abusers with HIV and other 
chronic diseases (e.g., diabetes, 
hypertension, heart disease) 
Grounded Theory 
 
Semi-structured interviews (SI) in 
three focus groups (FG) 
 
Purposive sampling 
 
Recruited from three community-
based health centres 
n = 31; aged 21 to 67 years (mean 
age = 50 years) 
 
All females 
 
Response rate not stated 
Six themes identified 
(1) Challenges pertaining to the management of comorbidities 
(2) Healthcare provider relationship 
(3) Mental health 
(4) Lack of social support 
(5) Nutrition 
(6) Access to health education  
 
An engaged and trusting relationship with their healthcare provider 
and having positive sources of support were reported as motivating 
treatment adherence. PLWH expressed more concerns with 
difficulty treating their comorbidities compared to managing only 
HIV. 
Anku et al. 
(2017) 
 
 
Ghana (four regions) 
TB-HIV co-infected patients 
 
Normalisation Process Theory: 
inductive and deductive approaches. 
 
SI 
 
Purposive sampling  
12 health facilities (separate, linkage, 
collaborative and fully integrated) 
 
n = 40; no data on age provided 
 
No data on gender provided 
 
Response rate not stated 
Three themes identified 
(1) Coherence: sense-making of TB-HIV service integration 
(2) Experiences of co-infected patients 
- Opportunistic TB or HIV diagnosis 
- Inconsistencies in co-therapy administration 
- Separate clinic appointment dates for TB and HIV 
- Late TB diagnosis and prolonged TB treatment due to drug 
resistance 
(3) Views of co-infected patients on services received under 
the various models 
  
Participants with HIV and TB were diagnosed opportunistically, 
leading to treatment inconsistencies. Participants expressed 
negative experiences especially those accessing care in separate 
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 facilities. 
Bova et al. 
(2010) 
 
 
USA 
White – 48.7% 
Hispanic – 38.5% 
African American – 12.8% 
 
HIV and HCV co-infected 
patients 
 
Age ≥ 18 
Qualitative descriptive methods and 
qualitative content analysis 
 
SI 
 
Purposive sampling and later 
theoretical sampling  
 
Three HIV specialty clinics 
 
n = 39; age range = 34-56 years 
(mean = 45.1 years); 54% male 
Response rate not stated 
Six major themes identified as treatment barriers or treatment 
facilitating factors: 
Treatment barriers 
(1) Treatment fears 
(2) Vicarious experiences 
Treatment facilitators: 
(3) Experience with illness management  
(4) Patient-provider relationships 
(5) Gaining sober time 
(6) Facing Treatment head on 
 
Chileshe et al 
(2010) 
 
 
Zambia (rural) 
Most belonged to the Tonga 
ethnic group  
HIV/TB co-infected patients 
 
Ethnographic case-studies 
 
SI 
 
Sampling strategy not stated; 
government health facility 
 
7 patients; Age range 21 – 54 years.  
 
n = 7; 3 females and 4 males 
 
Response rate not stated 
 
Two themes identified 
(1) Barriers to accessing ART: Economic, Social, Health 
facility  
(2) Outcomes – death, denial and transformation. After 
starting ART, an improvement in symptoms and a 
healthier physical appearance were perceived as positive. 
Clouse et al. 
(2018) 
 
 
South Africa 
 
Postpartum HIV-positive 
women with non-
communicable diseases (NCD, 
Inductive/deductive approach 
 
Open-ended interview (OI) 
 
Sampling strategy not stated, 
Three themes identified: 
(1) Maternal factors (Knowledge of importance of care for 
mother and baby and follow-up care) and (Motivation to 
attend clinic/take ART linked to how mother feels 
currently, amount of medication at home, pre/post baby 
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e.g., hypertension and diabetes) 
 
Age ≥ 18 
recruitment site: Health Research 
Unit at hospital. 
 
n = 25; median age = 36 years 
 
Response rate not stated 
complications; and perception of baby and mother’s 
health) 
(2) Environmental factors (Clinic type and clinic operations) 
(3) Social Networks (male partners, shared condition, advice 
giving). 
Most women reported receiving care for HIV and the NCD in the 
same clinic. Barriers to follow-up included separate visit days and 
subsequent increased time commitment, long waits and misplaced 
paperwork, and experiencing enacted stigma from staff at the HIV 
clinic.  
 
Factors facilitating treatment adherence and care included social 
support and disclosure of HIV to partner. Women were more likely 
to turn to friends, partners and family for advice regarding HIV or 
the NCD, rather than a clinic. 
Daftary 
(2012)*1 
 
 
South Africa 
Adults with HIV/TB co-
infection 
    
Age 18 – 50 years 
Modified Grounded Theory 
 
SI 
 
Purposive sampling;  
Recruitment site: three ambulatory 
clinics providing TB and/or HIV care 
 
n = 40; age range = 21 – 47 years 
(average age = 34) 
24 women; 16 men 
 
Response rate not stated 
 
Five themes identified  
(1) Distinguishing TB from HIV  
(2) Linking TB to HIV 
(3) The visibility of TB/HIV 
(4) Silencing HIV 
(5) Foregrounding tuberculosis 
 
TB vs. HIV identity was associated with separate degrees of stigma 
linked to participants’ experiences of labelling, negative 
stereotyping and discrimination.  
Patients deflected the dominant stigma of HIV through processes of 
HIV ‘othering’ – their symbolic distancing from persons affected 
by HIV, and ‘covering’ – their selective disclosure of illness (and 
identity associated) with TB over that of HIV.  
 
Daftary et al. 
(2012)*1 
South Africa 
Patients with HIV/TB co-
Modified Grounded Theory 
SI 
Five themes identified:  
(1) Income and employer support  
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infection 
Age 18 – 50 years  
 
Purposive sampling; three urban/peri-
urban ambulatory clinics. 
 
n = 40; 24 women and 16 men; age 
range = 21 – 47 years 
Response rate not stated 
(2) Access to social assistance 
(3) Disclosure versus support 
(4) Delays with ART 
(5) Fears to adhere 
 
Many patients were unemployed and unable maintain a steady 
income source. Government-issued disability grants were a 
common source of temporary financial aid. Patients negotiated TB 
and HIV disclosure with caution. Disclosure was required to gain 
access to social and financial support, but the degree of information 
shared was balanced against the risk of losing support. TB only was 
often disclosed. 
Daftary et al. 
(2013)*1 
 
 
South Africa 
Patients with HIV/TB co-
infection 
Age 18 – 50 years 
Modified Grounded Theory 
OI and exploratory interviews 
 
Purposive sampling 
 
Three urban/peri-urban ambulatory 
clinics. 
 
n = 40; 24 women and 16 men; age 
range = 21 – 47 years 
 
Response rate not stated 
Five themes identified 
(1) Missed opportunities for integration 
(2) Fragmented care 
(3) HIV nondisclosure 
(4) Contrasting clinic experiences 
(5) Patient preferences 
Participants encountered missed opportunities for TB and HIV 
service integration, and fragmented care for their dual infections. 
These issues appeared to impact participants’ health-related 
decisions, particularly HIV nondisclosure to non-HIV healthcare 
workers.  
Daftary et al. 
(2014) 
 
 
South Africa 
Inpatients with HIV and multi- 
or XDR-TB 
 
Thematic analysis 
FG 
 
Purposive sampling; Specialist TB 
hospital  
 
n = 23; age range = 18 – 56 years 
(median age = 36 years) 
Three themes identified 
(1) Preferential adherence to ART 
(2) Greater social morbidity of drug-resistant TB 
(3) Lack of education and support for XDR-TB 
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10 males and 13 females 
 
Response rate not stated 
Daftary et al. 
(2007) 
 
 
 
South Africa 
Inpatients with HIV and multi 
or XDR-TB 
 
Thematic analysis 
 
SI 
 
Purposive non-representative 
sampling; Recruitment site: TB 
hospital 
n = 21; 10 males, 11 females average 
age = 31.9 years 
 
Response rate not stated 
Two themes identified 
(1) Experiencing and perceptions of stigma and disclosure 
(2) The relationship between TB and HIV/AIDS  
 
Only themes relating to post-testing experiences are reported in this 
section: Patients were less likely to disclose their HIV status than 
their TB status. Patients received emotional support when they 
disclosed their TB illness to relatives, who appeared to make some 
connection between TB and HIV. Many co-infected patients 
preferred the singular disclosure of TB illness outside their network 
of close confidantes. TB was easier to speak about because it was 
less stigmatised and curable. 
Farrell et al. 
(2014) 
 
 
Location appears to be Ireland 
(not clearly stated) 
Ethnicity not stated 
Patients with HIV/HCV co-
infection 
Age ≥ 18 
 
Hermeneutic interpretive 
phenomenology. 
 
OI 
 
Purposive sampling 
 
Outpatient clinic at a large national 
hospital 
n = 5; 3 males, 2 females 
 
Response rate not stated 
Six themes identified 
(1) A Defining moment  
(2) HIV versus HCV (anxieties)  
(3) Loneliness/Relationships 
(4) Coping with Stigma 
(5) Care (received) 
(6) Awareness of Mortality 
Participants described defining negative moments in their lives that 
resulted in developing positive health care strategies. Participants 
considered HIV manageable; however, HCV was more of a 
treatment burden. Participants feared rejection following a 
disclosure of HIV and chose to cope with stigma by disclosing only 
to close family members. Participants talked about significant 
relationships in their lives and the supporting roles these 
relationships played.  
Furin et al. India Thematic analysis Three themes identified 
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(2014) 
 
 
Patients with HIV and MDR-
TB 
 
In-depth interviews 
 
Purposive Sampling; Outpatient 
MDR-TB treatment program 
supported by MSF 
 
n = 12; 8 males; 3 females; 1 
transgender person; age range = 25 – 
55 years 
 
Response rate not stated 
(1) Long pathways before MDR-TB treatment initiation 
(2) Diagnostic and treatment fatigue 
(3) Lack of faith in treatment efficacy 
Gebremariam et 
al. (2010)*2 
 
 
Ethiopia 
Patients with HIV/TB co-
infection 
Giorgi’s phenomenological method 
 
In-depth interviews and FG 
 
Maximum variation sampling 
strategy; 3 Health centres 
 
n = 15 TB/HIV co-infected patients 
age range not stated. 
 
7 males and 8 females 
 
Response rate not stated 
Eight themes identified 
Facilitators: 
(1) Beliefs about TB, TB treatment and co-infection 
(2) Pill burden and side effects 
(3) Lack of food 
(4) Interaction with health personnel 
(5) The challenges of DOT 
(6) Timing of ART  
(7) Stigma 
(8) Social Support 
 
Participants identified factors that increased adherence to TB 
treatment, and those that acted as barriers. 
Gebremariam et 
al. (2011) *2 
 
 
Ethiopia 
Patients with HIV/TB co-
infection 
Giorgi’s phenomenological method 
 
In-depth interviews and FG 
 
Maximum variation sampling 
strategy; 3 Health centres 
 
Two themes identified 
(1) Lay beliefs about the cause of TB 
(2) Associations between HIV and TB 
 
The majority of patients were aware of an association between TB 
and HIV. Participants identified weight loss as a hallmark of HIV-
related TB. The majority of patients believed that people in the 
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n = 15 TB/HIV co-infected patients 
(in addition; mean age 36.8 years, 
range 20 – 47 years. 
 
7 males and 8 females 
 
Response rate not stated 
community knew that there was an association between TB and 
HIV, and some feared that this would lead them to experience HIV-
related stigma. 
Ion et al. (2013) 
 
 
Canada 
 
5 Canadian White; 1 Canadian-
born Aboriginal; 1 – Black 
Caribbean descent 
 
Patients with HIV and 
symptomatic HSV-2 co-
infection 
 
Hermeneutic phenomenological 
reflection and thematic analysis 
 
In-depth SI 
 
Type of sampling method not stated; 
HIV clinic 
 
n = 7; age range 38 – 57 (average 46 
years old) 
 
All female 
 
Response rate not stated 
 
 
 
 
 
Three themes identified: 
(1) Overall health-related quality of life (HRQoL) and 
acceptance of HIV and HSV-2 infections 
(2) To ‘‘swim’’: Experiencing positive HRQoL (Controlling 
disclosure, Social and spiritual support, Setting and 
maintaining boundaries in relationships) 
(3) To ‘‘sink’’: experiencing negative HRQoL (Uncertainty, 
Anxiety, Negative body image) 
 
  
Isaakidis (2013) 
 
 
 
India 
Patients with HIV/MDR-TB 
co-infection 
Patients with HIV and MDR-
TB 
Analytic method not clearly stated – 
appears broadly thematic 
 
In-depth interviews 
 
Purposive sampling; MSF clinic 
Three themes identified 
(1) Accessing treatment: “The last chance” 
(2) Being on treatment 
(3) Staying on treatment 
Fragmented, non-integrated care and delays in initiation of effective 
treatment. Being on treatment resulted in medication side effects, 
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n = 12 patients 
 
8 males; 3 females; 1 transgender 
person; age range = 25 – 52 years. 
 
Time since HIV comorbidity 
diagnoses 
 
Response rate not stated 
 
and impacted participants financially as they could not work. Most 
patients had disclosed their HIV status only to their spouses and 
parents, but not to friends or the extended family. This limited 
patients’ and their families’ chances of seeking social and 
emotional support to cope. Family caregivers were crucial to 
maintaining the mental and physical health of patients.  
Lekas et al. 
(2011) 
 
 
USA 
African American or Puerto 
Rican 
HIV/HCV co-infected patients 
who were current or past 
injecting drug users. 
 
Analytic method not stated – broadly 
thematic. 
 
In-depth interviews 
 
Type of sampling method not stated; 
2 large public AIDS clinics. 
n = 132; Age range = 30 – 69 years 
(mean age = 49.9 years) 
 
69% men and 31% women 
 
Response rate not stated 
Eight themes identified 
(1) HIV is more stigmatising than HCV 
(2) Societal features of HIV, embodied features of HCV 
(3) HIV is perceived as more deadly than HCV and therefore 
more stigmatizing 
(4) The impact of HIV hygienic degradation rituals on HCV 
felt stigma 
(5) Perception of HCV as a contagious disease. 
(6) The public’s ignorance about HCV 
(7) The participants’ ignorance about HCV 
(8) HCV and HIV are equally stigmatizing because they imply 
drug use 
 
 
Matima et al. 
(2018) 
 
 
South Africa 
Patients with HIV and type 2 
diabetes (T2D) 
Thematic content analysis 
 
In-depth interviews 
 
Convenience sampling; 
Community health centre treating 
both HIV and diabetes 
Two themes identified: 
(1) Perceived patient workload (Clinic-related, self-
management) 
(2) Perceived patient capacity (Positive attitudes, Health 
literacy, Family support, Clinic-based support; Financial 
challenges to meet nutritional and clinic visits expenses) 
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n = 10 patients average age = 46.9 
5 males and 5 females 
(results for healthcare workers not 
stated in this systematic review); 
 
Response rate not stated 
Participants experienced “clinic-related workload” such as: the 
workload of attending two separate clinics for HIV and T2D and 
perceived and experienced power mismatch between patients and 
healthcare workers. Self-management related workloads were 
largely around nutritional requirements, pill burden, and stigma.  
 
The burden of these demands varied in difficulty among 
participants due to “capacity factors” outlined above. 
 
Monroe et al. 
(2013) 
 
 
 
USA 
African American (94%) 
Editing style analysis 
 
FG 
 
Sampling method not stated; HIV 
clinic 
 
n = 35; age range = 43- 63 (mean age 
= 51 years) 
 
Male 54%; Females 46% 
 
Response rate not stated 
Four themes identified:  
(1) Comorbidities are a source of concern and frustration, 
sometimes eclipsing concern regarding HIV 
(2) Understanding of health conditions and medications 
promoted adherence (e.g., Effects of missed doses of 
medication, Linking disease manifestations and/or 
symptoms to not taking medication) 
(3) Simpler regimens with fewer side effects promote 
adherence 
(4) Untreated substance abuse and mental health issues hinder 
adherence (Substance abuse leads to difficulty engaging in 
care, Depression contributes to non-adherence to 
medications lifestyle recommendations) 
Russ et al. 
(2012) 
 
 
USA 
Asian Americans Patients HIV 
and HBV or HCV co-infection. 
Thematic analysis 
 
SI 
 
Respondent driven sampling; 
Recruitment site – Health Centre 
 
n = 17; age range = 20 – 61 (median 
= 46 years) 
 
Two themes identified 
(1) Individual and structural barriers to care 
(2) Stigma 
 
Participants recognized the need for integrated, 
culturally and linguistically appropriate access to care while 
simultaneously acknowledging that stigma is a severe barrier to 
access to care. 
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n = 16; 14 Males; 2 Transgender 
male to female. 
 
Response rate not stated 
Sinclair et al. 
(2011) 
UK 
11 White British; 2 White 
Other 
HIV-infected gay men who had 
undergone HCV treatment 
Interpretative phenomenological 
analysis (IPA) 
 
SI 
 
Sampling Method not stated. HIV 
medical centre. 
 
n = 13; age range = 27 – 46 years 
 
Response rate not stated 
Four themes identified: 
(1) HCV diagnosis and treatment 
(2) HCV treatment education 
(3) Change in sense of self 
(4) Sexual risk-taking 
 
Patients undergoing HCV treatment felt that HCV treatment 
experience was in some way more overwhelming than HIV 
treatment, carrying with it a greater sense of uncertainty and 
despair. Education and reliable information appeared to help foster 
a more general sense of empowerment over HIV-HCV co-infection 
and treatment. For some, non-adherence became the more adaptive 
strategy to fit their experience of life and living. 
Warren-
Jeanpiere et al. 
(2014) 
USA 
African American 
HIV- positive. 22/23 women 
experienced co-morbid 
conditions such as cancer, 
diabetes, heart disease, 
hepatitis, TB. 
Constant comparison approach 
(inductive approach) 
 
SI 
 
Purposive sampling; research study 
sites 
 
n = 23; age 52 – 65 years (mean age 
= 57 years) 
 
Response rate not stated 
Four themes identified: 
(1) Taking one day at a time: Women’s definitions of HIV 
self-management (meanings attached to HIV self-
management and the social roles that influence women’s 
self-management behaviours) 
(2) Age ain’t nothing but a number (indicates that women do 
not place chronological boundaries on their age and that 
age is a state of mind) 
(3) Forget the single life (describes women’s perceptions of 
the influence of romantic male companionship on their 
self-management behaviours and outlook for the future. 
(4) Daily life struggles (illustrates the barriers that many 
women face in their everyday lives, including lack of 
income and health insurance that influence their ability to 
self-manage their HIV and other comorbidities to their 
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Note.  HBV – Hepatitis B; HCV – Hepatitis C Virus; HSV – Herpes Simplex Virus; T2D – Type 2 diabetes, NCD – Non-Communicable Disease, 
MDR-TB – Multi-Drug Resistant Tuberculosis; XDR-TB – Extensively Drug-Resistant Tuberculosis. SI – Semi-structured interview; OI= Open-ended interview; FG = Focus group. 
*1 = separate articles published using the same sample; *2 separate articles published using the same sample
satisfaction and suggests that HIV is not women’s primary 
concern when it comes to self-managing their overall 
health) 
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Synthesising findings 
A narrative synthesis approach was used to identify and understand key findings from 
the included studies (Popay et al., 2006). In the first stage of this narrative synthesis, the 
author extracted the overarching themes presented by each study to identify themes 
most frequently discussed within the included studies. Using these overarching themes 
as a framework, subthemes and more detailed description were subsequently extracted 
from each study. Relationships between themes were explored. Initial analysis revealed 
five overarching themes that were frequently reported by the included studies: (1) 
Management of HIV and comorbid physical health conditions; (2) Psychological 
outcomes of HIV and comorbid physical health conditions; (3) Preferences for care (4) 
Stigma; (5) Disclosure. The key findings related to each of these five overarching 
themes are summarised here. Please refer to Table 4. Qualitative synthesis for example 
quotations. 
Management of HIV and comorbid physical health conditions 
Studies reported that many participants experienced difficulties managing HIV and 
comorbid physical health conditions. Themes linked to this were present in 13 of the 
studies. Many participants found HIV easier to manage than comorbid physical health 
conditions, especially when multiple medications did not control comorbid physical 
conditions.  Participants experienced a lack of faith in treatment efficacy for comorbid 
physical conditions, particularly when early treatment had not worked. Participants 
spoke about how treatment barriers, including taking multiples medications for HIV and 
comorbidities were linked to forgetfulness and mixing up medication, fear of treatment 
and side effects. In addition, intentional non-adherence to treatment (i.e., 
missing/altering doses to suit one's needs) emerged as a maladaptive coping strategy to 
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help regain short term quality of life. Treatment facilitators included simpler regimens 
with fewer side effects. Some participants reported that experiencing physical 
manifestations of their illnesses motivated them adhere to treatment. Prior experience 
with illness management was helpful and participants discussed using strategies 
developed over time to manage these chronic conditions as a way to manage additional 
conditions. Participants reported that setting reminder alarms helped them to integrate 
taking medication into their daily routine. Participants believed positive attitudes helped 
them to accept and cope with living with HIV and comorbid conditions. Participants 
reported that having confidence in medical treatment, a supportive family, and strong 
beliefs in religious or cultural practices helped them to cope with their comorbidities.  
Psychological outcomes of HIV and comorbid physical health conditions 
Themes around psychological outcomes of HIV and comorbid physical health 
conditions were identified in 10 of the studies. Symptoms often made full-time work 
difficult to maintain and this moved participants towards economic hardship, alongside 
food insecurity, particularly where hospitalisation occurred (e.g., for extensively drug-
resistant TB – XDR-TB, a form of TB which is resistant to at least four of the core anti-
TB drugs). The nutritious food required by participants was expensive, and difficult to 
sustain. This impacted on treatment adherence as many believed it was more difficult to 
tolerate medication without it. Access to financial assistance was scarce and where this 
did exist, eligibility was conditional (e.g., a function of participants’ CD4 count). As 
treatment could raise CD4 counts above the eligibility threshold, this resulted in 
participants feeling powerless and resentful of the governing system of social 
assistance. Many participants subsequently experienced depression and anxiety dealing 
with HIV and comorbidities and felt that mental health services from organizations they 
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were recruited from were inadequate. Participants with HIV and herpes simplex virus-2 
(HSV-2) experienced anxiety and reduced health related quality of life linked to fear of 
potential transmission of HSV-2 and HIV to intimate partners, and fear of disclosure 
resulting in rejection and judgement from others. For some participants achieving good 
physical and mental quality of life was associated with how they perceived their HIV-
positive status and how they made efforts to shift their self-perceptions to be “in a good 
place” (for HIV and HSV-2). 
Preferences for care  
Themes around preferences for care of HIV and comorbid physical health conditions 
were identified in 12 of the studies. Participants discussed the positive aspects of their 
relationships with health care providers and how these relationships helped them adhere 
to their medication regime. However, for some participants, disrespectful treatment by 
clinical staff occurred, often due to HIV stigma directed at participants. Participants 
described wanting more support and empathy from healthcare workers regarding their 
difficulties in managing comorbid conditions. Some found healthcare related 
information anxiety provoking, and others reported how not being given information 
about treatment side effects led them to feel that they coped more poorly with them. 
Participants with XDR-TB were very isolated and many felt demoralised and wanted to 
be encouraged and informed about their prognosis by healthcare workers. Several of 
these participants described how health providers informed their family about XDR-TB 
diagnoses, but did not provide additional information on how to live with it. This led to 
participants experiencing discrimination from family members. Participants wanted to 
be given the responsibility to take TB treatment in the same way that they had been 
counselled for ART, so that they would return home and self-administer medication. 
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Participants described wanting to learn skills to discuss their health more assertively 
with clinicians. Participants also reported that they would like to attend educational 
programmes on managing and understanding their comorbidities. Many participants 
expressed a wish for more integrated care as they had experienced delays in initiation of 
treatment which led to them feeling emotionally exhausted from a long help-seeking 
journey. Where fully integrated clinics did not exist, participants mentioned issues 
relating to inconsistencies in care and treatment for all illnesses (e.g., no access to 
previous medical test results between clinics). Separate clinic appointments dates and 
treatment failures appeared to lead to mixed messages about treatment which, in some 
cases, led to drug resistance. Many participants at non-integrated sites expressed interest 
in accessing integrated care. Some however preferred to attend separate clinics, fearing 
that accessing HIV services at integrated care sites would lead to their HIV status being 
disclosed to all other patients. 
Stigma 
Themes around stigma were identified in seven of the studies. Participants regarded 
HIV and comorbid conditions distinctly. TB was perceived as common and curable and 
those infected were not viewed as being at fault for having contracted it. HIV instead 
was considered to be more selective, affecting people based on their personal character, 
which left them vulnerable to contracting it. TB was seen as an interim setback to 
participants’ routine lives that could be managed with treatment, and this prompted less 
concern.  Many participants however believed that other people associated TB with 
HIV, as weight loss was viewed as an embodied sign of HIV illness. Many had seen 
HIV patients experiencing stigma and discrimination in their communities and feared 
this would happen to them. Participants experienced hepatitis C (HCV) as less likely to 
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evoke rejection and that it elicited compassion from others when attention was drawn to 
its physical features such as “malfunction of the liver”, thus deflecting social 
stigmatization. Where participants reframed HCV as a physical illness that could be 
transmitted in a variety of ways, this appeared associated with a reduction in stigma and 
feelings of shame, in particular compared to HIV. Participants internalized others’ 
attitudes about HIV which affected their self-perceptions. An HIV diagnosis invoked 
blame and shame, and worries about being gossiped about or viewed as infectious and 
disgusting. Participants also experienced sadness and fear linked to appraisals of HIV as 
permanent and related to death. Participants described examples of consequences of 
stigma including not being able to get a mortgage on a house because of an HIV 
diagnosis. After being diagnosed with TB, several working in temporary jobs reported 
not being permitted to have leave with many being dismissed from employment as 
employers worried about their infectiousness. Participants reported that this was also 
linked to TB’s stigmatizing association with HIV. HIV-related stigma interfered with 
participants’ journeys to acceptance of HIV. Participants who had come to terms with 
living with HIV and HSV-2 presented a positive perception of self and comfort with 
their identity. Others expressed regret for becoming infected and blamed those who they 
believed gave them HIV and HSV-2, and experienced poor health and quality of life.  
Disclosure 
Disclosure decisions linked to HIV and comorbid physical health conditions were 
difficult for many participants. Themes around disclosure were identified in 15 of the 
studies. Many participants considered HIV to be more stigmatising than their comorbid 
illnesses and only disclosed this to their spouses and parents, but not friends or extended 
family.  Participants with TB spoke about it more readily and with more people than 
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HIV. Selective disclosures (i.e., disclosing to some people but not others) were tied to 
TB invoking less judgement and being considered curable and more acceptable than 
HIV. Although participants revealed how TB disclosure was easier than HIV, they 
realized that discussing TB could invoke suspicions about HIV. For participants with 
HSV-2, having control over disclosure reduced stress and enabled participants to 
maintain positive health related quality of life. Participants disclosed their HIV status to 
those they identified as trustworthy and who they predicted would be there in difficult 
times. When conversations were had with others about HIV, participants felt overtly 
discriminated, due to their perceived contagiousness. This perpetuated a sense of guilt, 
shame and helplessness, and led many to hide their illnesses. Several participants spoke 
about the embarrassment and loss of self-respect in taking Directly Observed Therapy 
(DOT – whereby treatment doses are observed in person by a health care professional) 
at the doctor’s clinic which they believed outed their TB and HIV status. In addition, for 
participants with HIV and HCV, being exposed to enacted stigmatization in the form 
“hygienic degradation rituals” (e.g. designating particular plates for participants’ sole 
use and disinfecting bathrooms) after disclosing their HIV status to friends and family, 
resulted in intense HIV felt stigma. These participants anticipated being subjected to 
similar HCV degradation rituals, which led to them concealing their HCV status and 
thus generated HCV felt stigma. Participants with HIV and hepatitis B or C 
(HBV/HCV) co-infection reported that they withheld information to avoid situations 
that would compromise their anonymity when accessing general health care as a means 
of protection against stigma. Most participants did not disclose HIV to employers, and 
accessed “vacation”/unpaid leave for HIV care. Non-disclosure limited participants’ and 
their families’ chances of seeking social and emotional support to cope, and resulted in 
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social withdrawal. Participants identified living with HIV and HVC as a lonely life 
linked to fear of rejection following disclosure of HIV. The difficulty of disclosure 
further undermined their ability to access ART, and social support was found to be 
crucial for participants’ treatment. Families were a source of encouragement and 
comfort for those participants who had lost hope. Participants reported that family 
support was important and where it was lacking or totally unavailable, it led to distress 
and difficulties in managing HIV/T2D (Type 2 Diabetes; Matima et al., 2018). 
  
53 
 
 
 
Table 4. Qualitative synthesis 
Category Theme Example 
Management of 
HIV and 
comorbid physical 
health conditions 
HIV is easier to 
manage than comorbid 
physical health 
conditions 
“So hepatitis C, over the next, certainly currently and for the future will have more of an impact on me. And the HIV, through my self-
care but mostly because of the medication and good fortune, has become a manageable lifetime illness, like diabetes is or asthma is, 
which is remarkable considering the point from which we started. Hepatitis C is another bag of chips and unfortunately I have – I 
underwent the treatment in ‘03 and ‘04 that was extremely difficult and to which I didn’t fully respond, so I probably face a slightly 
uncertain future there.” (Farrell et al., 2014) 
Treatment barriers e.g. 
pill burden, side effects 
“To speak about myself, I really think it is difficult to express. Taking so many tablets, going through so much pain, I am fed up.” 
(Furin et al., 2014) 
Treatment facilitators 
e.g. simpler regimen, 
responsibility for 
treatment (via 
education) 
“But this last [regimen], I can thank God that I’m not detectable and . . . this one is great-just one pill once a day,” and for diabetes, 
“my insulin . . . I was taking like 4 shots . . . Now I got the pen. The new pen that I stick myself twice, one in the morning, one in the 
evening. And that’s awesome.”  
(Monroe et al., 2013) 
Psychological 
outcomes of HIV 
and comorbid 
physical health 
conditions 
Psychological 
difficulties 
‘‘you get depressed, you don’t eat, so you don’t take your medication.’’ (Amutah-Onukagha et al., 2018) 
Psychological coping 
responses 
“Just taking care of myself one day at a time to manage it. But just help me to manage it and live a productive life to a well-being as I 
possibly can. Just help me to manage like I do the rest of my ailments and carrying on to, you know, to be a balance in everything.” 
(Warren-Jeanpiere et al., 2014) 
Preferences for 
care 
Relationship with 
healthcare provider  
“They [MSF staff] stood by me. They gave me emotional support, helped me find courage. R [nurse] said if ever I did not feel well, or 
felt that I needed to talk, I was to give her a missed call [on her mobile phone] and then she would call back. (…) It was like she was 
with me all the time, to help me whenever I needed help. (…) They have cared for me – more than my blood relatives.” (Isaakidis, 
2013) 
Service Integration “I prefer the one-stop-shop approach because, I don’t like to be moving ‘up-and-down’ the various units for treatment. Having 
treatment at the same facility and under the same roof for both infections and on the same date will be comfortable for me. That will 
also give me the opportunity to discuss with them [service providers] about my condition regarding both infections and it will also give 
them the chance to discuss and agree on what to do for me at a point in time…When we move in and out of the place [care centres] like 
that, people get to see us and gossip about us. “ (Anku et al., 2017) 
Stigma  HIV versus other 
illnesses 
“They take it [TB] a usual thing because they say it’s usual, it’s in everyone. It means it’s a thing which doesn’t select. [HIV,] there it’s 
difficult for them to take easy. They tell themselves that as you have HIV-positive, you are the thing which will leave the world.” 
(Daftary, 2012) 
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Category Theme Example 
Stigma and embodied 
features of illness 
“More of the herpes and HPV than the HIV, yeah, because it’s right there in my face . . . I can feel that. It’s tangible. It hurts there. HIV 
is not tangible. You can’t feel it. You can’t see it.” (Ion et al., 2013) 
Consequences of 
stigma 
“Now you know the people, maybe the people don’t like. They looking at you with the mind not with the eyes. With the mind they 
looking at you. How can I put it? You feel shit, so to say. You not yourself that time, because you’re like, you go home, you  feel like 
demolish.” (Daftary et al., 2012) 
Disclosure Disclosure decisions “There they laugh at each other. If you ever say you have TB, they become your doctors. It’s them who will say, ‘Yes, of course, TB is 
AIDS’ neighbor. It means she has got AIDS’, you see?” (Daftary, 2012) 
Silencing illness status [I have not told my relatives] ‘cause, because, due to the fact that, hepatitis C is more, uh, I mean, a germ and a bacteria that’s picked 
up off of things. And then if I go to their house, and eat, you know, wondering when I leave, what are they doing, I mean, if they’re 
running to get Clorox, to wash this down, to do that, because see, I, experienced that with members of my family [for my HIV status]. 
(Lekas et al., 2011) 
Consequences of 
disclosure choices 
‘I was dealing with it all by myself. I used to cry quietly. My mother in law was also very sad when she found out. (…) I only told her 
[my sister] and no one else. She also said she would not tell anyone as it was not something one can tell easily. She did not even tell her 
husband. I did not even tell my brother as his wife may just blurt it out in front of other people. (Isaakidis , 2013) 
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Quality assessment 
For all studies: the sources of qualitative data were relevant to address the 
research question; and the process for analysing qualitative data was relevant to address 
the research question. For all studies except Farrell et al. (2014) appropriate 
consideration was given to how findings relate to the context. All studies except 
Amutah-Onukagha et al. (2018), Farrell et al. (2014) and Sinclair et al. (2011) did not 
give appropriate consideration to how findings relate to researchers’ influences. Please 
refer to Table 5. for an overview of this using the MMAT critical appraisal tool 
(MMAT – Pluye et al., 2011). 
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Table 5. MMAT Critical appraisal tool results 
Authors 1. Are the 
sources of 
qualitative 
data relevant 
to address 
the research 
question? 
2. Is the process for 
analyzing qualitative 
data relevant to 
address the research 
question? 
3. Is appropriate 
consideration given to 
how findings relate to 
the context? 
 
4. Is appropriate 
consideration 
given to how 
findings relate to 
researchers’ 
influences? 
SCORE out of 4 
(Score each Yes = 
1; No = 0) 
 
1. Amutah-Onukagha et al. 
(2018) Yes Yes Yes Yes 4 
2. Anku et al. (2017) Yes Yes Yes No 3 
3. Bova et al. (2010) Yes Yes Yes No 3 
4. Chileshe et al. (2010) Yes Yes Yes No 3 
5. Clouse et al. (2018) Yes Yes Yes No 3 
6. Daftary (2012) Yes Yes Yes No 3 
7. Daftary et al. (2012) Yes Yes Yes No 3 
8. Daftary et al. (2013) Yes Yes Yes No 3 
9. Daftary et al. (2014) Yes Yes Yes No 3 
10. Daftary et al. (2007) Yes Yes Yes No 3 
11. Farrell et al. (2014) Yes Yes No Yes 3 
12. Furin et al. (2014) Yes Yes Yes No 3 
13. Gebremariam et al. (2010) Yes Yes Yes No 3 
14. Gebremariam et al. (2011) Yes Yes Yes No 3 
15. Ion et al. (2013) Yes Yes Yes No 3 
16. Isaakidis et al. (2013) Yes Yes Yes No 3 
17. Lekas et al. (2011) Yes Yes Yes No 3 
18. Matima et al. (2018) Yes Yes Yes No 3 
19. Monroe et al. (2013) Yes Yes Yes No 3 
20. Russ et al. (2012) Yes Yes Yes No 3 
21. Sinclair et al. (2011) Yes Yes Yes Yes 4 
22. Warren-Jeanpiere et al. 
(2014) Yes Yes Yes No 3 
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Discussion 
Overview of study findings 
This review aimed to synthesise findings on the illness experiences of individuals living 
with HIV and comorbid physical health conditions. Twenty-two qualitative studies were 
included, drawing from a variety of population groups.  Five common themes emerged: 
(1) Management of HIV and comorbid physical health conditions; (2) Psychological 
outcomes of HIV and comorbid physical health conditions; (3) Preferences for care; (4) 
Stigma; (5) Disclosure. Previous systematic reviews have focused on the illness 
experiences and psychological outcomes of those with HIV alone (e.g., Breuer, Myer, 
Struthers & Joska, 2011; Lowther, Selman, Harding & Higginson, 2014), those with a 
different physical health conditions but without HIV (e.g., diabetes – Li, Drury & 
Taylor, 2014; cancer - Singer, Das-Munshi & Brähler, 2010), or HIV and a single 
comorbid health condition (e.g., for HIV and cancer – Hainsworth, Shahmanesh, & 
Stevenson, 2018). The current review examines the illness experiences of people living 
with HIV (PLWH) across a range of comorbid health conditions in low-, middle- and 
high- income settings. It is also only focused on qualitative studies compared to the 
above reviews. 
Participants from studies in the current review described experiencing difficulty 
managing HIV and comorbid health conditions. HIV was found to be easier to manage 
than comorbid physical health conditions (e.g., Farrell et al., 2014). Treatment barriers 
for HIV and comorbid physical health conditions were highlighted – including pill 
burden and side effects. Treatment facilitators were outlined as being a simpler 
treatment regimen for HIV and being provided with education and enough autonomy to 
take responsibility for HIV treatment. Evidence from a quantitative study not included 
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in the current review found that multiple drugs co-administered with ART are an 
important predictor of non-adherence due to the associated pill-burden, side effects and 
drug interactions (Cantudo-Cuenca,Jiménez-Galán, Almeida-González & Morillo-
Verdugo, 2014).  
In the current review, participants commented on their preferences for care, including 
experiences of relationships with healthcare providers and service integration. 
Participants appreciated feeling supported, however reports of stigma, not being given 
adequate information and not feeling involved in decision-making linked to services not 
being integrated were present in the literature. These findings were generally consistent 
across studies, and may help practitioners better recognize the specific need for patient-
centred care, with a focus on supporting and educating this population. HIV and 
comorbid physical healthcare education sessions could be offered to newly diagnosed 
patients to help them to feel more supported within the healthcare system. Session 
content and delivery could be informed by patient involvement. 
Findings of the review suggest that PLWH and comorbid physical health conditions 
experience stigma, in particular, stigma related to HIV versus other illnesses. The 
stigma associated with being diagnosed with HIV and comorbid physical health 
conditions impacted on people’s relationships and experiences with the healthcare 
system, as did the physical and mental health symptoms associated with HIV and 
comorbid health conditions (e.g. fatigue, weakness, nausea, pain, depression and 
anxiety). Petrak, Doyle, Smith, Skinner and Hedge (2001) reported high levels of HIV-
stigma and consequent mental health problems in a black African population in the UK, 
which fits with the findings of the current review. This study could not be included in 
the review as it included HIV-only participants. Misinformation and lack of education 
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may be the underlying cause of this stigma.  Education, within the healthcare system, 
for family and friends of individuals diagnosed with HIV and comorbid health 
conditions may reduce stigma associated with them (e.g., Pretorius, Greef, Freeks & 
Kruger, 2016).  
The current review highlighted that PLWH and comorbid health conditions experience 
psychological difficulties (e.g. Amutah-Onukagha et al., 2018). However, it is difficult 
to ascertain whether this is due to one illness over another, combined stigma or other 
factors. How individuals with HIV and comorbid physical health conditions specifically 
cope with stigma has not been explicitly explored. This is an area that would benefit 
from future research as it is unclear if, how and where HIV-positive individuals with 
comorbid physical health conditions access a range of support systems in addition to 
family (e.g., friends, religion, and support organisations). 
Participants commented on disclosure, including disclosure decisions, silencing illness 
status, and the consequences of disclosure decisions. Participants regarded HIV and 
comorbid conditions distinctly; disclosure decisions linked to HIV and comorbid 
physical health conditions were difficult for many participants. Studies in the current 
review found that fear of transmission of communicable diseases was a factor cited in 
contributing to deteriorating relationships. Previous research has discussed the 
difficulties surrounding HIV-only disclosure (Doyal, 2009; Evangeli & Wroe, 2017) 
and the presence and impact of HIV-only stigma (Doyal, 2009; Earnshaw & Chaudoir, 
2009). In addition, it has been proposed that a person’s view of the world and their 
assessment of how they are able to respond to difficult situations is critical for 
successful coping (Lazarus and Folkman, 1984; Lazarus & Lazarus, 1991). Participants’ 
ability to effectively cope and adjust to living with HIV and comorbid physical health 
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conditions appears to have been negatively impacted by stress linked to experiences of 
anticipated stigma. While it may be important for participants to disclose their HIV 
status to obtain needed resources and support, negative consequences may be associated 
with disclosure. Therefore, participants’ decisions related to disclosure of their HIV 
status are likely to be influenced by their evaluation of the positive or negative 
consequences of disclosure. 
Given the large amount of research into the psychological impact of being diagnosed 
with HIV across different populations, it was not surprising that the results of this 
review suggest that the experiences of PLWH and comorbid physical health conditions 
impact on psychological difficulties and coping responses. Also, in particular for 
individuals living in low income countries, poverty, housing difficulties and poor access 
to medical care negatively impacted on mental health.  This is in line with Moss-Morris’ 
(2013) ‘unified’ model of adjustment that cites multiple causal factors for poor 
adjustment that are relevant to individuals with HIV and comorbid health conditions. 
These factors include low socio-economic status, difficult treatment regimens and an 
uncertain future. Research in a high-income country – the UK – has also found that 
black African men and women living with HIV, reported difficulties in relation to 
employment, income, housing and residency status (Ibrahim, Anderson, Bukutu, and 
Elford, 2008). An additional area for research could include, quantitative research 
comparing how levels of mental health differ between individuals living with HIV and 
those living with HIV and comorbid health difficulties. This would allow insight into 
what the additional impact of living with a comorbid health condition is on PLWH’s 
mental health in males and females of all age groups. 
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Strengths and limitations of the review 
A strength of the current review is that it was conducted across high- middle- and low- 
income countries: seven studies were conducted in South Africa, six in the USA, two in 
Ethiopia, two in India, one in Ghana, one in Zambia, one in Ireland, one in Canada, and 
one in the UK. For the studies that did provide information about the age of their 
participants, this was consistent with an age range between 18 and late sixties. This 
suggests that the findings of this review can be transferable across much of the adult age 
span and to similar contexts. Another strength of the review process was that eligible 
studies and study quality were independently reviewed by a second reviewer with the 
resolution of any disagreements by a third reviewer. This practice helped to increase the 
reliability of decision making during the review process. An additional strength of the 
review process is that the quality of all included articles was assessed. This enabled 
informed decisions to be made about the reliability of studies’ findings and whether 
they provided meaningful answers to the review question. The Networked Digital 
Library of Theses and Dissertations was used to search for unpublished and grey 
literature, which provided a more comprehensive view of the literature available. As a 
recommended approach was used to analyse the qualitative data (Popay, 2006), this is 
another strength of the review. This allows for the review to be replicated and increases 
the transferability of the results found. 
A limitation of the search strategy was that the key terms were only searched for in the 
titles and abstracts and the authors were not contacted to determine additional 
demographic information. The search strategy was deemed efficient given the limited 
resources available for the review. Whilst this method enabled the majority of relevant 
articles to be found, a more comprehensive search strategy may have found additional 
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articles. There may have been studies missed by the electronic search. To further 
increase the likelihood of all relevant papers being identified citation chaining (i.e., 
searching backwards and forwards in time for materials that are cited by and also that 
cite an article or resource already found) could have been used. This would help 
improve robustness of the search and the likelihood that all of the relevant papers were 
identified. 
Another limitation was the exclusion of non-English language studies. This limits 
transferability of findings to other settings/speakers of languages other than English. In 
addition, the findings from Anku et al. (2017), which focus on management of 
comorbid health conditions, need to be interpreted with care as the authors provide no 
demographic information about age or gender. Without this information, transferability 
is unclear. There were also issues resulting from the quality appraisal. These include the 
relatively low number of papers (four papers) where the researcher authors clearly 
acknowledged their contribution (and potential for bias) to the research findings. In 
addition, the Kappa agreement score reflecting inter-rater reliability (i.e., how different 
assessors respond to the same questions and how consistently they score the response) 
was moderate. Scales which are designed to give a summary ‘quality’ score can lead to 
an over-simplification of quality assessment and can have greater risk of problems with 
inter-rater reliability. This may be linked to researcher influences, for example where 
the undergraduate student-rater had less familiarity and expertise with the research 
process. This may have impacted on the importance they attached to rated features of 
the articles. To help improve inter-rater agreement among inexperienced raters, a pilot 
phase could occur where raters rate the quality of a subsample of articles to allow for 
the identification and clarification of areas of ambiguity. 
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Research implications 
The review has many implications for future research. A future systematic review into 
this topic would benefit from a search strategy including searching for terms in the body 
of the article text as well as titles and abstracts. This may increase scope and allow for 
additional articles to be found, increasing knowledge of this area. HIV stigma is a theme 
that was elicited in many articles looking at individuals living with HIV and comorbid 
health conditions. Further research into the anticipated and experienced HIV-stigma that 
individuals living with HIV and comorbid physical health conditions face would aid 
understanding of how stigma related to HIV and other physical health conditions 
emerge in this population.  Limited education and knowledge about HIV in low income 
countries has been found to lead to beliefs that support stigmatizing attitudes (Bos, 
Schaalma, & Pryor, 2008). In addition, Nyblade, Pande, Mathur, MacQuarrie, and Kidd 
(2003) found that many individuals linked behaviours that led to HIV with going 
against religious teachings and as a punishment from God due to sins being committed.  
Additionally, culture-informed beliefs exist about HIV, for example that it is caused by 
witchcraft in Tanzania and Zambia (Nyblade et al., 2003). Nyblade et al. (2003) also 
identified demographic factors that shape stigmatizing attitudes, for example individuals 
with low socioeconomic status were found to experience more stigma because of their 
inability to hide their status and seek the best care. It would be helpful to delineate 
specific cultural factors that contribute to stigma across different cultures and countries 
to help inform intervention efforts. It could also support researchers and healthcare 
practitioners in learning how best to minimise it. Also, other than non-disclosure, little 
is known about the strategies used by individuals with HIV and comorbid physical 
health conditions to cope with stigma. Research into these areas across a range of 
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settings may suggest changes that would greatly enhance the support that is offered to 
these groups. 
Future research would also greatly benefit from providing more detailed demographic 
information about their participants. This includes: ages of participants, time since HIV 
and other physical health diagnoses, and sexual orientation, including whether 
participants are men who have sex with men (MSM). This would allow readers to gain 
an understanding of the participants included in the studies and allow for more effective 
comparison of studies looking at different risk groups. Future research into whether 
these themes are prevalent in other populations would be helpful. Studies included in 
the review did not refer to theories of adjustment. This may have been helpful when 
thinking about the wellbeing and mental health of HIV-positive individuals living with 
comorbid physical health conditions. For example, Leventhal, Meyer & Nerenz (1980) 
proposed the Common Sense Model (CSM) of illness representations – that individuals 
develop simultaneous cognitive and emotional representations about their illness, which 
can influence the way they appraise and manage their illness. Offering HIV and 
comorbid physical healthcare education sessions to newly diagnosed patients may help 
them to feel more supported within the healthcare system. Information provided on 
managing HIV and comorbid health conditions could support patients with the cognitive 
aspects of adjustment around illness beliefs, supporting them to learn coping strategies 
that can make managing their illnesses easier, reduce feelings of threat and increase 
beliefs about treatability and controllability. This can positively impact adherence. For 
example, intentional adherence is associated with the balance of perceived benefits and 
losses of taking medication, and the extent to which participants were prepared for the 
effects of medication (Wroe & Thomas, 2003). 
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Practice implications 
This review has highlighted implications for future practice. The UK Standards of Care 
for People Living with HIV (PLWH) state that, “People living with HIV should receive 
care and support that assesses, manages and promotes their emotional, mental and 
cognitive well-being and health, and is sensitive to the unique aspects of living with 
HIV” (British HIV Association - BHIVA, 2018, p. 50). In addition, it states that “People 
with several long-term conditions, who face economic hardship and/or who have 
alcohol or substance use problems are more likely to have mental health difficulties that 
may be more complex. The standards for psychological care are likely to be of 
particular importance” (BHIVA, 2018, p. 41). The psychosocial needs of HIV-positive 
individuals with comorbid physical health conditions are not outlined in detail here and 
it remains a relatively under-researched area. BHIVA also advocates for the use of care 
coordinators as “People with multiple needs will often have a number of agencies or 
services involved in their care, but they may also be the least able to make best use of 
these services and face challenges in attending the multiple appointments that are often 
required (British HIV Association – BHIVA, 2018, p. 41). Given that this review has 
highlighted difficulties of living with HIV and comorbid physical health conditions, 
more could be done to help support this population to access and receive psychological 
support. Psychological support is defined as “any form of support which is aimed at 
helping people living with HIV to enhance their mental health and their cognitive, 
emotional and behavioural wellbeing” (BHIVA, 2011, p.72). To help improve the 
support offered to PLWH and comorbid physical conditions, individuals who are not 
accessing psychological support, the situated-Information Motivation Behavioral Skills 
Model of Care Initiation and Maintenance is useful to draw on (Rivet Amico, 2011). 
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The model proposes that for someone to receive psychological support they or someone 
else: needs to be aware that they have difficulties that are appropriate for psychological 
support; needs to have the motivation to seek psychological support; and they or 
someone else needs to have the skills to obtain psychological support. These areas could 
be explored with patients, their families and healthcare professionals to find out what 
support PLWH and comorbid conditions would find most helpful to promote patient 
centred care. 
In addition, psychoeducation could be provided on aspects of living with HIV and a 
physical health condition to patients alongside their friends and family. This may help 
to reduce the impact of stigma associated with living with these conditions. 
Psychological interventions such as Acceptance and Commitment Therapy (Hayes, 
Strosahl  & Wilson, 1999) and Compassion Focused Therapy (Gilbert, 2009) have been 
found to help promote flexibility of responses to experiences of societal stigma and 
increase compassion whilst decreasing shame (i.e., an affective state linked with self-
stigma) in a group of PLWH (Skinta, Lezama, Wells & Dilley, 2015). Such 
interventions could be provided in services with care taken to deliver these in culturally 
informed ways. BHIVA (2011) states that PLWH are entitled to screening to identify 
psychological support needs. It might be helpful to complete an audit on the number of 
people with HIV and comorbid physical health conditions receiving this, and the type of 
support offered and taken up. Demographic information could also be collected. Where 
screening doesn’t happen, it would be helpful to identify reasons for this, and how to 
support clinicians with this. Where individuals are from black and minority ethnic 
(BME) communities living in high income countries, they are less likely to be offered or 
to take up, and more likely to drop out of, talking therapies (BHIVA, 2011). It is 
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suggested that clinicians discuss any potential difficulties and discuss support options 
(including services specifically for BME communities) with this group. This can 
support individuals to develop and maintain social relationships. BHIVA (2011) also 
recommends that PLWH should receive confidential and non-stigmatising care. The 
findings of the review, suggest that it may be helpful for clinicians to place emphasis on 
discussing confidentiality and building trust when working with PLWH and comorbid 
health conditions to help promote engagement. 
  
68 
 
 
 
3. Developing a model of the individual and social processes of 
living with HIV and TB co-infection in UK migrants 
Abstract 
In the last two decades, TB has re-emerged in the UK, linked to HIV infection and 
today’s migratory phenomenon. HIV/TB co-infection is of psychological interest in UK 
migrants as stigma is associated with both conditions and may affect psychological, 
social, and physical adjustment. Experiences of being a migrant may complicate 
adjustment to HIV/TB co-infection including immigration status, acculturation and 
discrimination. No research has focused on adjustment for migrants with HIV/TB co-
infection in high income countries. Interviews with nine participants (six males and 
three females; 33- 63 years) were analysed using Grounded Theory Methodology. A 
theory was developed that aims to explain the individual and social processes involved 
in living with HIV/TB co-infection in UK migrants who were recruited via two HIV-
services across London. Semi-structured interviews were transcribed and coded. Seven 
theoretical codes were identified 1). Migrating to the UK 2) Ideas of HIV and TB prior 
to receiving diagnoses 3) Accessing healthcare up to the point of receiving HIV and TB 
diagnoses 4) Experiences whilst accessing specialist HIV and TB care 5) Managing 
disclosure of HIV and TB 6) Managing mental health after receiving HIV and TB 
diagnoses 7) Appraisal and coping with HIV and TB. The findings suggest that delayed 
access to care impacted the mental health of participants. Participants also anticipated 
stigmatising responses to disclosure of HIV and preferred to disclose about TB - linked 
to its perceived curability. Participants reported good relationships with healthcare 
professionals and many drew on religious beliefs to help them make sense and cope 
with their illness challenges. The research could help increase the confidence and hope 
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of people living with HIV and TB. In addition, it could help increase knowledge and 
confidence of healthcare professionals and other agencies in how best to support 
migrants living with HIV/TB co-infection in a high-income setting.  
Introduction 
HIV 
HIV is a virus that damages the cells in the immune system and weakens its ability to 
fight everyday infections and disease (for more details on HIV, see the Executive 
Summary on p.7). Treatment consists of Antiretroviral Therapy (ART) which fights 
HIV by interfering with the reproduction of the virus in the body (WHO, 2017). HIV 
continues to be a major global public health issue. In 2018, 37.9 million people globally 
were living with HIV with 1.8 million people newly infected with HIV in that year 
(UNAIDS, 2018). In 2017, 102,000 people were living with HIV in the UK with 4,363 
people were newly diagnosed with HIV (PHE, 2018a). The UK government has set out 
a commitment to end transmission of HIV in England by 2030 (DHSC, 2019). 
Tuberculosis (TB) 
TB is an infectious disease and the leading preventable cause of death worldwide for 
people living with Human Immunodeficiency Virus (HIV).  TB usually affects the 
lungs, but TB-causing bacteria can attack any part of the body. When TB enters a 
person’s immune system the bacteria may be cleared, the individual may become 
unwell with active TB, or the bacteria may enter a state of equilibrium with the immune 
system in which the host remains well but the bacteria remain ‘dormant’ – this is latent 
TB (LTBI). TB treatment typically entails taking antibiotics for several months. 
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Multidrug-resistant TB (MDR-TB) is TB that does not respond to at least isoniazid and 
rifampicin, the two most powerful anti-TB drugs (WHO, 2018). 
TB accounts for around one in three AIDS-related deaths (UNAIDS, 2018). In 2017, 
10.1 million people were diagnosed with TB, and of those, approximately 9% were 
living with HIV, largely in low- and middle-income countries (UNAIDS, 2018). It is 
estimated that 49% of people living with HIV and TB are unaware of their HIV/TB co-
infection and are not receiving care (UNAIDS, 2018). HIV and TB infection and 
disease can increase the progression of one another (Mayer & Hamilton, 2010). In the 
last two decades, there has been a resurgence of TB in the UK, linked to HIV infection 
and increased migration of people from areas of the world where TB is more common 
than in the UK (Lönnroth et al., 2015). In 2017, there were there were 5,102 UK cases 
of TB (WHO, 2018). In England, the prevalence of HIV co-infection among TB 
patients is between 5-9% (Kruijshaar et al., 2010), with 80.1% of HIV/TB co-infected 
individuals being non-UK born (PHE, 2018b). Of note, non-pulmonary TB is not 
presented in PHE annual reports as it does not present a public health risk to others.  
In 2014, PHE and the National Health Service (NHS) in England launched a 
“Collaborative Tuberculosis Strategy” to address the “marked contrast” between the 
higher incidence of TB in England compared to other high-income countries in Europe 
and North America (PHE, 2015). The ambition of the strategy was “to strengthen TB 
control, with the aim of achieving a year-on-year decrease in incidence” (PHE, 2015). 
In 2018, the first ever UN high level meeting on TB took place and set targets to treat 
40 million people with TB by 2022. 
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HIV and TB pose multiple adjustment challenges. Similarities and differences exist 
between TB and HIV: TB is curable, whereas HIV is not; both conditions are infectious 
and have potential public health risks, but with different transmission routes; treatment 
for active TB can be complicated and prone to side effects than HIV. In addition, both 
conditions can remain latent/undetected for many years and require monitoring one’s 
health to reduce the risk of negative health effects (WHO, 2012).  
Migration 
There is no consensus on a single definition of a ‘migrant’. Definitions of ‘migrant’ 
vary across data sources, and between datasets and law. Migrants might be defined by 
foreign birth, by foreign citizenship, or by their movement into a new country to stay 
temporarily (sometimes for as little as a year) or to settle for the long-term. Worldwide, 
the incidence of TB rises with rising levels of deprivation. In high-income, low TB-
incidence countries however, TB is also associated with immigration (Suk et al., 2009). 
The majority of HIV/TB co-infection cases – 80.1% in England (PHE, 2018b) occur in 
people who are foreign born. Migrants with HIV or TB can encounter challenges such 
as communication problems, loss of social support and adapting to new surroundings, 
which can impact on accessing healthcare and complicate adjustment to these illnesses. 
Many may have undergone traumatic experiences pre-migration such as loss, separation 
from loved ones and violence (Warfa et al., 2012). They may also experience enacted 
stigma - perceived actual experiences of stigma and discrimination (Ho, 2004; Kulane, 
Ahlberg, & Berggren, 2010).  Migrants with TB have been found to anticipate 
discrimination and rejection from others (Coreil, Lauzardo, & Heurtelou, 2004; Tardin, 
Dominice Dao, Ninet, & Janssens, 2009). In addition, individuals try to safeguard 
family dignity (Shiu, Park, & Kearns, 2008) by not disclosing their TB diagnosis to 
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family or friends, which in turn reduces access to long-term support. Within the migrant 
populations, stigma has also been linked to culturally-held beliefs. For example, within 
the Sub-Saharan African population in Belgium, HIV stigma is linked to beliefs about 
HIV affecting “bad people”, and those who were sexually deviant (Manirankunda, 
Loos, Alou, Colebunders & Nöstlinger, 2009). Such attitudes towards HIV may 
influence the way migrants perceive and manage living with HIV in high-income 
countries (i.e., a country with a gross national income per capita of US $12,056 or more, 
World Bank, 2019).  
At present a research gap exists for understanding more about the role of stigma for 
migrants with HIV/TB co-infection in low prevalence/high income countries. It is 
important to note that although the term “migrant” is widely used in the academic 
literature, in public discourse it has, for some, developed xenophobic connotations. This 
is partly linked to news coverage from particular media outlets, alongside policies 
explicitly designed to restrict access to public services for people without the legal right 
to live in the UK. Research in the area must take care when using the term “migrant” to 
avoid reifying the experience of this heterogeneous group. 
Stigma 
Stigma has been conceptualised as a socially ‘devalued attribute’ which in turn affects 
the way people react to knowledge that they do or do not possess the devalued attribute. 
HIV has been offered as an example of such an attribute (Earnshaw & Chaudoir, 2009). 
Previous research with individuals with HIV has identified three forms of stigma that 
may be directed at HIV. Internalised stigma, enacted stigma and anticipated stigma (see 
p.19 for definitions; Earnshaw et al., 2013). Research with people with HIV has found 
that these different types of stigma result in greater social burden of illness and can 
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delay accessing medical care and decrease treatment adherence (Bogart et al., 2011; 
Gary, 2005).  
Disclosure of HIV status is a psychosocial challenge for people with HIV and 
internalised stigma is a barrier to disclosure and linked to less perceived support 
(Overstreet, Earnshaw, Kalichman & Quinn, 2013). Disclosure is linked to positive 
health behaviours including adherence to treatment in people newly diagnosed with 
HIV (Hult, Wrubel, Bränström, Acree & Moskowitz, 2012). Support within 
relationships can provide comfort for people living with HIV (Harvey & Wenzel, 2002) 
and also facilitates adherence to treatment for people with TB (Ito, 1999). However, 
disclosure can leave people with HIV vulnerable to negative social evaluation from 
family, friends, sexual partners and employers and result in greater stigmatisation 
(Derlega, Winstead, Greene, Serovich & Elwood, 2004). Research with individuals with 
TB also shows that disclosure can impact negatively on holding employment (Kirwan, 
Nicholson, Baral, & Newell, 2009). 
With regard to HIV/TB co-infection, research on stigma has occurred in high 
prevalence settings. For example, a South Africa based study (Daftary, 2012) found that 
HIV/TB co-infection resulted in a ‘double stigma’ where identities associated with TB 
became more undesirable and stigmatised. Participants perceived TB as making visible 
their HIV status. This reinforced the stigma of having HIV and perpetuated and renewed 
stigma against TB, impacting negatively on disclosure of both. Also, greater 
perceived/anticipated TB stigma has been found to be associated with non-disclosure of 
HIV/TB co-infection in a high incidence setting with the potential to negatively impact 
on relationships (Hayes-Larson et al., 2017). Ethnographic work has highlighted how 
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social barriers including stigma, nondisclosure and a lack of support challenge HIV/TB 
patients’ help-seeking for dual care (Chileshe & Bond, 2010).  
Psychological models of adjustment 
Adjustment to HIV diagnosis is a complex and difficult task. Many aspects of HIV 
diagnosis are stressful, for example, the need to adhere to treatment, fear of death, 
disclosure decisions and interactions with a complex medical system. The Transactional 
Theory of Stress and Coping (Lazarus & Folkman, 1984) proposes that coping is part of 
a process in response to the demands of a situation that is appraised as stressful. A meta-
analysis (Moskowitz et al., 2012) of types of coping that related to psychological 
wellbeing in people with HIV found that “direct action” (e.g. finding a healthcare 
provider) and “positive re-appraisal” (e.g., “I have learned something from this 
experience”) were associated with better outcomes for people coping with HIV. Social 
support can also moderate adjustment and coping to an HIV diagnosis (McDowell & 
Serovich, 2007; Peterson et al., 1996; Schmitz & Crystal, 2000). 
Moss-Morris’ (2013) model of adjustment aims to take a unified approach to the 
adjustment of chronic conditions and cites multiple causal factors for poor adjustment 
that are relevant to individuals with HIV and/or TB, including migrants. These factors 
include a change in identity and life roles, lower levels of social support and socio-
economic status, difficult treatment regimens and an uncertain future. This model 
suggests good adjustment is represented by less distress, less impact on identity/life 
roles and relationships, good illness management and positive affect. This highlights 
that individuals can be in adjustment equilibrium and disequilibrium at different times. 
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The Common Sense Model (CSM; Leventhal, Meyer & Nerenz, 1980) of illness 
representations is also relevant to individuals with HIV and/or TB. It proposes that 
individuals develop simultaneous cognitive and emotional representations about their 
illness, which can influence the way they appraise and manage their illness. These are 
proposed to include five main cognitive domains: 1) identity (illness label and 
symptoms), 2) timeline (beliefs about how long the illness will last), 3) consequences 
(beliefs about the physical and social impact the illness will have), 4) cause (beliefs 
about the perceived cause of illness), and 5) perceived controllability/curability of the 
illness. In addition, a non-cognitive domain of emotional perceptions of illness (e.g., 
degree of worry or fear) is included.  
Many studies into the effects of diagnosis have drawn parallels between it and the grief 
process (Kübler-Ross & Kessler, 2005). There can be a mourning for the loss of the self 
who was unaffected by health problems. In the same way as grieving, adjusting has 
been proposed to be a process rather than an event. The stages of grief (Kübler-Ross, 
1969) can be a framework for understanding the adjustment to diagnosis. Stages to the 
process include (1) Denial ‘This can’t be happening’; (2) Anger ‘Why me?’, ‘It’s not 
fair’, ‘who is to blame?’; (3) Bargaining ‘If only I could have done things differently’; 
(4) Depression ‘I’m so sad’, ‘what’s the point?’, (5) Acceptance, ‘It’s going to be OK’, 
‘I can take control and manage this’. Not everyone with a diagnosis will experience all 
of these emotional reactions, or in this particular order. Many people will shift between 
a number of these stages over many years. 
Adjustment to HIV is challenging and many experience depression (Do et al., 2014; 
Sherr et al., 2011). Research on the link between HIV/TB co-infection and depression 
and anxiety has occurred in Ethiopia (a high prevalence HIV/TB co-infection region) 
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where higher rates of both mental health difficulties have been found for those with 
HIV/TB co-infection versus those solely with HIV (Deribew et al., 2010). These 
findings however cannot be generalised to UK migrants given the many differences in 
socio-medical contexts, and no research has focused on adjustment for migrants with 
HIV/TB co-infection in high income countries. HIV/TB co-infection in the context of 
migration may come with particular adjustment challenges. These include changes in 
medical context, with greater medication availability and differences in integrated care 
which may impact on adjustment. 
Migrants may also be more isolated, with difficulties adjusting to a different 
country/language (Ho, 2004). Uncertainty of immigration status is a mental health risk 
(Kirmayer et al., 2011), and as TB is a statutorily notifiable disease, this may potentially 
impact on presenting for care and adjustment for some migrants. For TB, directly 
observed therapy (DOTS) treatment schedules that expect patients to attend to a TB 
clinic in their community daily, can reinforce existing stigma (Craig, Daftary, Engel, 
O’Driscoll, & Ioannaki, 2017).  These adjustment difficulties may also be applicable to 
migrants with HIV/TB co-infection in low prevalence/high income countries, and 
further research on this is required. 
Rationale for the current study 
The literature supports the view that stigma is associated with HIV and TB and may 
affect presenting to care, treatment adherence, HIV/TB disclosure, psychological, social 
and physical adjustment and mental health outcomes. Research on HIV/TB co-infection 
has often occurred in high prevalence regions – for example, on experiences of stigma 
(Daftary, 2012) and disclosure (Hayes- Larson et al., 2017) and their potential to 
negatively impact relationships. These findings, however, cannot be generalised to UK 
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migrants given the many differences in socio-medical contexts, and no research has 
focused on adjustment for migrants with HIV/TB co-infection in low prevalence/high 
income countries. 
The current study will address this gap by using a sample of UK migrants with HIV/TB 
co-infection. The term migrant is used in the current study to refer to any person who 
has come to reside outside the nation in which they were born. The change in setting is 
important as it is possible that the perceived impact of living with HIV/TB co-infection 
may be influenced by having lived in different settings. Also, there could be culturally-
held beliefs linked to this, and this is an under-researched area.  An increased 
understanding of the experience of UK migrants living with HIV/TB co-infection may 
aid the development of interventions focused on supporting adjustment in this 
population. Questions will be asked about participants’ experiences of having each 
condition respectively and HIV/TB co-infection. In addition, further questions on 
perceptions of having these diagnoses in their country of birth and in the UK will be 
asked to understand more about culturally-held beliefs. 
Research aims and question 
The aim of the study is to develop a model of the individual and social processes 
involved in living with HIV and TB in UK migrants. The study aims to answer the 
following research question: 
What is the perceived impact for UK migrants living with HIV/TB co-infection on 
disclosure of both conditions, relationships, help-seeking, identity and adjustment? 
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Method 
Research design 
A cross-sectional qualitative design was used, drawing on Grounded Theory (Charmaz, 
2006) to design, analyse and report the findings of nine semi-structured interviews with 
UK migrants who had been diagnosed with HIV and TB co-infection. 
Participants 
Fourteen participants were approached by clinicians involved in their care at two HIV 
clinics, and nine people who fit the inclusion criteria agreed to participate in the study 
(see Table 6 for further demographic details). In addition, one person was recorded on 
the patient database as being foreign born and he was interviewed after consenting to 
take part. On discussion with him, it was found that he was born in the UK but migrated 
abroad and then returned to the UK. As this meant that he did not fit the selection 
criteria, his data were not eligible to be used. Out of the fourteen participants 
approached, four participants (three females and one male) declined to take part. The 
most common reason cited was worry that being interviewed about their experiences 
would be too emotionally distressing. 
Inclusion and exclusion criteria 
Inclusion criteria: 
• Participants were migrants (i.e. a person born outside the UK). This includes 
both long- and short-term migrants. 
• Received a positive HIV test at any time from three months onwards, and a TB 
diagnosis between three months to five years at the time of interview. This 
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timeframe allowed for some adjustment to diagnosis, and for some post-test 
events to occur that are in line with the research questions. Participants with 
active, latent or cured TB were included.  
• Participants were of any gender and 18 to 64 years old. 
• All participants had a degree of English Language proficiency (i.e. 
understanding and responding to questions in English) to help ensure they could 
fully engage in the interview. This was assessed by clinicians at the relevant 
service. 
Exclusion criteria: 
• Evidence of significant risk of harm to self or others (e.g., self-harm, suicidal 
ideation). This was assessed by clinicians at the relevant service. 
Recruitment source 
Participants were recruited at specialist HIV-services with HIV/TB joint clinics at two 
London hospitals. Patients accessed these services following a referral by sexual health 
clinics, other hospital departments or GPs once they were diagnosed with HIV 
infection. Staff at the HIV services included HIV consultants, clinical nurse specialists 
and health advisers. 
Data collection 
Interviews 
Data were collected via face-to-face semi-structured interviews (audio recorded). The 
interview schedule (Appendix A) was developed by the researcher and reviewed by 
academic and field supervisors. Questions asked were linked to participants’ 
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experiences of HIV and TB before being tested for each condition, how they came to be 
tested for HIV and TB, experiences of finding out a positive result for HIV and TB, 
attendance at specialist clinics, taking medication, relationships with healthcare 
professionals prior to and after diagnosis, HIV and TB disclosure, relationships with 
family, friends, sexual partners and employers, and how they felt about having HIV/TB 
co-infection. 
Feedback on the interview schedule was sought from a service user who did not fully 
meet the study’s inclusion criteria (i.e., he was diagnosed with HIV; and with TB more 
than five years ago) on content and areas of the questions, and the language used. The 
service user commented on four aspects: First, he queried the use of the word ‘migrant’ 
on the participant information sheet as he wondered if this would be perceived as a 
stigmatising label. He reported that after reading through the interview protocol he felt 
more assured that the word ‘migrant’ was acceptable and that he did not think there was 
a better alternative word or phrase to be used. Second, he wondered how applicable it 
was to ask participants about what it was like learning English as a new language, as 
there may have learnt it a long time ago. He agreed that it would be useful to retain the 
questions as there may be participants who had learnt English more recently. Third, the 
service user commented on his own experience of increasing his alcohol intake to help 
himself cope with his HIV and TB diagnoses and advised that a question on coping and 
substance use could be included. Fourth, he commented on his experience of how 
continuity of care can be compromised if different clinics are accessed and to include a 
question on this. The interview schedule was adapted in response to the feedback 
comments. A mock interview with the academic supervisor provided further 
81 
 
 
 
opportunity to practice using the interview schedule, refine questions, and receive 
feedback. 
Measures 
Participants completed a demographics questionnaire to provide additional contextual 
information (Appendix B). Participants’ most recent Viral Load, CD4 count and 
treatment information were obtained from their medical records (Appendix C). The 
Hospital Anxiety and Depression Scale (HADS, Zigmond & Snaith, 1983; See Table 7) 
was also completed by participants, as it has been identified as a useful screening tool 
for depression in HIV populations (Savard, Laberge, Gauthier, Ivers & Bergeron, 1998) 
and can help contextualise the qualitative experiences of participants.  
Grounded theory 
Grounded Theory methods are suitable for studying individual processes, interpersonal 
relations and reciprocal effects between individuals and larger social processes. The 
approach is also useful for studying personal experiences and emotions (Charmaz, 1995, 
cited in Smith, Harré & Van Langenhove, 1995). Grounded Theory’s distinctive feature 
is that it facilitates the development of theories to explain behaviour (Charmaz, 1998) 
that can provide further understanding of many processes present for the HIV/TB co-
infection population. In the context of adjustment in UK Migrants with HIV/TB co-
infection, this is particularly applicable because many of the key processes after 
receiving a diagnosis are social (e.g. disclosure to friends, family, partners and 
employers, help-seeking and discussing the diagnosis and management of both 
conditions with health professionals). The resulting model was grounded in the data to 
allow for suggestions of causal connections that could support the development of 
HIV/TB co-infection interventions facilitating adjustment. 
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Table 6. Participant Demographic Information 
Pt # Age at 
interview 
(years) 
Gender Employment 
status 
Relationship 
Status 
Children Region of 
birth 
Immigration 
Status 
Time in 
UK 
(years) 
Time since 
diagnosis 
(years) at 
interview 
Most 
recent 
CD4 
count 
(cells/uL; 
time 
since) 
Most 
recent 
Viral load 
(copies 
m/L; time 
since) 
On 
ART 
TB 
Treatment 
(duration) 
1 33 Male Employed In a 
relationship 
and living 
together 
No Europe EEA 
National 
5 HIV (1yr 
2m) 
TB – P & 
LN (1yr 
1m) 
350 
(1m) 
435 
(1m) 
Yes Treated 
– Ended 
(6m) 
 
2 53 Female Employed Married No Southern 
Africa 
EEA 
National 
10 HIV (1yr 
9m) 
TB – 
MDR, P 
(1yr 8m) 
452 (1yr) <20 
(8m) 
Yes Treated 
– Ended 
(1yr 7m) 
3 42 Male Unemployed In a 
relationship 
but not living 
together 
Yes East 
Africa 
UK National 24 HIV (1yr 
7m) 
TB – LN; 
P; brain 
abscesses 
(1yr 7m) 
238 
(5m) 
51 
(1m) 
Yes Treated 
– Ended 
(11 m) 
4 34 Male Employed Single No Europe EEA 
National 
9 HIV 
(6yrs) 
TB - P 
(1yr 11m) 
785 
(11m) 
31 
(6m) 
Yes Treated 
– Ended 
(6m) 
5 54 Male Unemployed Married – 
separated and 
not living 
together 
Yes South 
Asia 
EEA 
National 
3 HIV (2yrs 
11m) 
TB - P 
(2yrs 
11m) 
750 
(1yr 6m) 
<20 
(1m) 
Yes Treated 
– Ended 
(1yr) 
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Pt # Age at 
interview 
(years) 
Gender Employment 
status 
Relationship 
Status 
Children Region of 
birth 
Immigration 
Status 
Time in 
UK 
(years) 
Time since 
diagnosis 
(years) at 
interview 
Most 
recent 
CD4 
count 
(cells/uL; 
time 
since) 
Most 
recent 
Viral load 
(copies 
m/L; time 
since) 
On 
ART 
TB 
Treatment 
(duration) 
6 43 Male Unemployed In a 
relationship 
but not living 
together 
No West 
Africa 
Asylum 
seeker 
awaiting 
decision 
5 HIV (1yr) 
TB – D 
(1yr) 
143 
(1m) 
81 
(1m) 
Yes Treated 
– Ended 
(1yr) 
7 49 Female Unemployed Single Yes Southern 
Africa 
Indefinite 
Leave to 
Remain 
16 HIV (9yrs 
2m) 
TB - Sp 
(1yr 10m) 
358 
(5m) 
<40 
(5m) 
Yes Treated 
– Ended 
(1yr) 
8 50 Male Unemployed Married Yes East 
Africa 
Indefinite 
Leave to 
Remain 
13 HIV 
(11yrs) 
TB - P 
(4yrs 6m) 
412 (7m) <20 
(1m) 
Yes Treated 
– Ended 
(9m) 
9 63 Female Employed Single Yes South-
east Asia 
Expired 
tourist visa 
18 HIV (2yrs 
4m) 
TB - LN 
(2yrs 4m) 
275 
(1m) 
94 
(1m) 
Yes Treated 
– Ended 
(6m) 
              
Note. Participants’ regions of birth are specified rather than countries of birth to retain anonymity. An undetectable viral load is <50 copies/mL; TB – MDR = Multi-Drug Resistant; 
P = Pulmonary; LN = Lymph node; D = Disseminated; Sp = Spinal. 
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Theoretical sampling and theoretical saturation 
Grounded Theory methodology often makes use of theoretical sampling – the process of 
data collection directed by evolving theory rather than predetermined population 
dimensions (Strauss, 1987). Data collection should continue until theoretical saturation 
(also known as data saturation) is met (when no new information or themes can be 
observed in the data). However, there is little guidance on the sample size needed for 
saturation to occur (Guest, Bunce & Johnson, 2006; Vasileiou, Barnett, Thorpe & 
Young et al., 2018). The study aimed to use theoretical sampling but given the limited 
time-frame to recruit participants and four participants declining to take part, this was 
not possible. All available participants were recruited. For the current study, the 
specificity of the research aims and the constrained inclusion criteria – foreign born 
individuals who have been diagnosed with HIV and who have had a diagnosis of TB 
within the past five years – meant that the study was more likely to reach saturation of 
themes with a relatively small sample. However, the relatively small sample size meant 
that theoretical sufficiency was unlikely to have been reached - where all categories 
were developed to a sufficient extent to explore their relationships and draw conclusions 
(Charmaz, 2006; Dey, 1999). 
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Table 7. Self-reported Hospital Anxiety and Depression Scale 
Participant # HADS 
Anxiety score1 
HADS 
Depression score2 
P1 4 1 
P2 4 1 
P3 3 6 
P4 6 3 
P5 16* 16* 
P6 7 9 
P7 4 10 
P8 2 0 
P9 13* 7 
Note. 1 0-7 normal anxiety, 8-10 mild anxiety, 11-14 moderate anxiety, 15-21 severe anxiety 
2 0-7 normal depression, 8-10 mild depression, 11-14 moderate depression, 15-21 severe 
depression. * Indicates a clinically significant score. 
 
Reflexivity 
A constructivist approach views research as constructed, rather than discovered, which 
in turn fosters the researcher’s reflexivity about their actions and decisions (Charmaz, 
2006). Charmaz (2006) advises that researchers reflect on their own preconceptions of 
the data and the research process to ensure that the researcher’s position, privileges, 
perspective, and interactions are accounted for as part of the research reality. As the 
researcher for this study, I am a 36-year old, Iranian-White heterosexual, female Trainee 
Clinical Psychologist. For part of the study I was working in a sexual health and HIV-
service and this experience has helped me understand some of the issues facing those 
living with HIV such as concerns around stigma, disclosure and adjusting to living with 
a health condition. In addition, hearing about a family relative of mine experiencing TB 
in Iran at a time when treatment was not readily available increased my interest in the 
area. I believe it is valuable to think about individual and systemic ways of 
conceptualising presenting concerns and I try to maintain a curious stance (Cecchin, 
1987) to help develop and revise a multiplicity of views relating to individual and social 
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processes. This stance contributed to the way that I understood difficulties associated 
with HIV and TB, such as stigma and adjustment. I had some understanding about HIV 
and TB prior to the study. 
Procedure 
Participants were sampled systematically from HIV-specialist services. All eligible 
participants were provided with information about the study by their clinicians via a 
telephone call or on the day of their appointment. If participants were interested in 
taking part and consented to be contacted by the researcher, they were either telephoned 
or met after their appointment and taken to a separate clinic room to discuss the study 
further. For those who were interested in taking part, a suitable time to complete the 
interview was arranged. Prior to starting the interview, the researcher gained informed 
consent which included going through the Participant Information Sheet (Appendix D), 
informing participants that they could withdraw from the process at any time, that the 
interview would be stopped immediately if they become upset or wished to terminate 
their involvement, the boundaries of confidentiality and how their data would be stored. 
Consent forms were signed by participants and the researcher (Appendix E). 
Nine participants first completed the demographics questionnaire and then HADS 
between October 2018 and March 2019. Interviews were face-to-face and conducted in 
private rooms within the HIV clinics. Interviews lasted between 66 and 97 minutes 
(mean of 82 minutes). At the end of the interview, participants were provided with the 
opportunity to debrief and reflect on the experience. No participant left the interview 
demonstrating any clear distress. 
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Payment 
Participants were paid with a £10 voucher for participating in the study. Travel 
expenses (up to £12) were reimbursed if they travelled to the clinic on a non-
appointment day to participate in the study. All participants gave receipt of payment 
(Appendix F). 
Analysis 
Transcription 
The audio-recorded interviews were transcribed verbatim by the primary researcher 
onto a computer for coding. The primary supervisor commented on an uncoded 
transcript. 
Coding 
Charmaz (2006) describes coding as the process of actively processing and naming the 
verbal data, and defining what is happening within the data. Coding within Grounded 
Theory occurs in three stages: First, open coding is used to generate a range of ideas and 
occurs inductively in the initial stages. Fragments of data (e.g., words, lines and text) 
are assigned names or codes to explore what is happening in the data. During this stage, 
the researcher conducted careful sentence-by-sentence coding for each transcribed 
interview. The internal supervisor verified the codes of two transcripts. 
Second, with continuous data collection and simultaneous analysis, the coding becomes 
focused to explore reoccurring codes prevalent in the data. This process allowed the 
researcher to link together initial codes and make phenomena explicit that the 
participants might not have actively conceptualised (Appendix G). The internal 
supervisor verified the focused codes. Discussions between the researcher and internal 
88 
 
 
 
supervisor were held to examine the language used to describe the focused codes and to 
ensure that the codes were mutually exclusive. The internal supervisor looked at the 
relationship between lower and higher order codes to check for coherence and the extent 
that the analysis was logical. Feedback was also provided where codes covered similar 
content and could be merged. Codes were modified and developed as a result of this 
feedback and discussion.  
Third, theoretical coding refined the final concepts. Focused codes were reviewed to see 
how they relate to each other, and then by reviewing memos, focused codes were 
shaped into theoretical codes and emergent Grounded Theory. Memos help minimise 
preconceptions of what the researcher thought was in the data, and help the researcher 
organise thinking about how the data fit together to form patterns and any emerging 
possible links between codes (Charmaz, 2006; Glaser & Strauss, 1967) (Appendix H). 
The internal supervisor also verified the theoretical codes and provided feedback on the 
language used to name the codes and the placement of the focused codes under each 
theoretical code. Following this, the internal supervisor provided peer review on the 
theoretical model and discussed with the researcher how the theoretical codes interacted 
with each in a diagram. 
Ethical approval 
Full ethical approval was gained from an NHS Research Ethics Committee (REC), as 
well as Research and Development (R&D) and Health Research Authority (HRA) 
approval, and approval from Royal Holloway University of London College REC. 
Ethical approval was received in July 2018 (Appendix I and J). 
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Ethical considerations 
During the interviews, participants were asked to talk about sensitive experiences and it 
was important to ensure that they gave informed consent to what their involvement in 
the research would entail. Clinicians at each testing site, who were already aware of 
potential participants’ HIV and TB-statuses, made the first point of contact. Participants 
were not contacted until three months post diagnosis to allow for some adjustment to 
diagnosis, and for some post-diagnosis events to occur for their experiences to align 
with the research questions. There was a named clinician at each testing site to offer 
support to participants if needed. 
Quality assurance 
Published guidelines on quality in qualitative research (Elliott, Fischer, & Rennie, 1999) 
were adhered to – Owning one’s perspective: The researcher kept memos throughout to 
maintain self-reflexivity on the research process. These memos covered information on 
theoretical orientations and personal anticipations – those known in advance and those 
that become apparent during the research;  Situating the sample: Participants’ 
demographic information can be found in Table 6 to aid the reader’s understanding of 
the sample and assess the transferability of findings; Grounding in examples: An extract 
of a transcript is included in Appendix G to show the process of interviewing and 
coding. The results section contains example quotes for each theme identified; 
Providing credibility checks: The internal supervisor provided credibility checks by 
reviewing and providing feedback on the interview schedule, interview style, coding 
and the developing theoretical model; Coherence: Coherence was aimed for by naming 
the theoretical codes and appropriately summarising the analysis whilst attempting to 
preserve nuances in the data. The emergent theory was mapped out diagrammatically 
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and a narrative of the model provided, to show clear and logical relationships among 
categories; Accomplishing general vs specific research tasks: Clarification of research 
conclusions that only apply to the participant group studied was made; Resonating with 
readers: The researcher aimed to present material in such a way that readers judge it as 
an accurate representation of the subject matter. This was done by examining and 
prioritising the language used by participants in the formation of codes and categories to 
support the validity of the resulting theoretical model. Data were presented in a way that 
expanded and sought to clarify readers’ understanding of individual and social 
processes involved in living with HIV/TB co-infection in UK migrants. 
Results 
Data analysis identified seven theoretical codes that form the proposed theoretical 
model.  These are shown in Table 8. The theoretical codes consist of 19 focused codes, 
each containing specific properties that were produced at the initial coding stage. A 
diagrammatic representation of the relationships between the theoretical codes is 
outlined and discussed. Quotes from the participants have been used to illustrate codes, 
and demonstrate how they are grounded in the data. Any identifiable participant 
information has been removed to ensure confidentiality, and the participants are referred 
by their designated participant number (P1 to P9).  
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Table 8. Theoretical Codes, Focused Codes, Initial Codes 
Theoretical codes Focused Codes Properties of the code (initial codes) 
Migrating to the 
UK 
Reasons for migrating Reflecting on pre-migratory life events 
Seeking new opportunities in the UK 
Life in the UK Enjoying living in the UK 
Thinking about immigration status 
Describing employment conditions 
Supporting families abroad financially 
Identifying cultural differences related to social 
interactions 
Ideas of HIV and 
TB prior to 
receiving 
diagnoses 
Perceptions of HIV and 
TB in countries of origin 
HIV being linked to death 
TB being considered common and linked to poverty 
Perceptions of HIV and 
TB in the UK 
Not hearing people talk about HIV or TB in the UK 
Accessing 
healthcare up to 
the point of 
receiving HIV 
and TB diagnoses  
 
Prior testing for HIV Receiving negative prior HIV test results 
Experiencing delays in 
HIV and TB testing 
 
Feeling unwell and visiting the GP and hospital 
multiple times 
Presenting for emergency care 
Having multiple medical tests in hospital 
Feeling frustrated at the diagnostic uncertainty  
HIV and TB Testing 
experiences  
Consenting to having an HIV test 
Not thinking about HIV or TB 
Experiences 
whilst accessing 
specialist HIV 
and TB care 
Receiving treatment for 
HIV and TB 
Feeling distressed by the pill burden  
Feeling distressed by medication side effects 
Identifying reasons for non-adherence of HIV 
medication 
Getting into a routine of taking HIV and TB 
medication  
Describing challenges of having additional physical 
health conditions 
Financial burden Not working and the financial impact of being 
unwell  
Describing precarious housing situations 
Relationship with 
healthcare workers after 
being diagnosed with HIV 
and TB 
Caring and trusting relationships with HIV and TB 
healthcare workers  
Feeling hope when provided with information from 
healthcare workers 
Frustration and disappointment regarding non-
responsive care 
Experiencing gratitude towards healthcare workers 
who provided support with gaining financial/housing 
entitlements 
Managing 
Disclosure of 
HIV and TB 
Disclosing HIV and TB 
status to others 
Telling others about being HIV+ and their responses  
Partners and family members being tested for HIV 
and TB 
Preferential disclosure of TB over HIV+ status 
linked to TB’s perceived curability 
Contemplating future disclosure of HIV 
Deciding not to disclose 
HIV and TB status to 
others 
 
 
 
Silencing HIV following HIV diagnosis 
Not wanting others to worry about their health 
Distress linked to breaches of confidentiality 
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Theoretical codes Focused Codes Properties of the code (initial codes) 
Managing mental 
health after 
receiving HIV 
and TB diagnoses 
Feelings following HIV 
and TB test results 
Feeling shock and disbelief following HIV and TB 
test results 
Experiencing worries and low mood 
Suicidal ideation and attempts 
Post-HIV and TB 
diagnosis and stigma 
Describing HIV and TB-stigma 
Expressing or experiencing race related stigma 
Accessing psychological 
and HIV specific support 
Attending HIV support organisations 
Identifying reasons for not attending HIV support 
organisations 
Being referred to and seeing mental health 
professionals 
Appraisal and 
coping with HIV 
and TB 
Thinking about how HIV 
was acquired 
Confusion over how HIV was acquired 
Anger towards/regarding perceived sources of HIV 
Religious beliefs/practices 
in the context of HIV and 
TB 
Feeling despair and praying to God for recovery 
Feeling protected by God 
Attending church  
Adjusting to living with 
HIV and TB 
Believing that TB can be cured 
Reminding oneself of undetectable HIV status 
Positives of knowing HIV status 
Hopes for the future Wanting to help others who are in need 
Wanting to return to work 
Hoping to socialise more and to be in a relationship 
 
Migrating to the UK 
Reasons for migrating 
Four people reflected on pre-migratory life events and included events ranging from 
traumatic events such as war and threats to life, to a stressful marital split.  
 
“I came from – from the wars, famine… the hardships and all that”. (P3) 
 
Eight participants spoke about coming to the UK to seek new opportunities including 
escaping from difficult pre-migratory life events, to gain an education and to work. 
Life in the UK 
Five participants commented on how much they enjoy living in the UK and five 
participants spoke about changes to their immigration status – three of whom have 
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experienced fear linked this. One participant, arrived on a student visa and was, at the 
time of interview, seeking asylum. This participant worried that being returned to West 
Africa would mean that he could not access medical care for an additional diagnosis of 
kidney disease: 
“What is really the problem with me is the dialysis, this alone. Going to [detail 
of West African country removed] with this is just like a death sentence, because 
I know of a lot of people that died because they could not, errm, meet up with 
the financial implications”. (P6) 
Another participant described the waiting period to receive indefinite leave to remain as 
“scary” (P7).  
One participant was in the UK on an expired tourist visa and she lived with the daily 
worry that she would be sent to prison. 
“They will catch me, they will catch me, then they will put me to the jail!”. (P9) 
All nine participants commented on working, and three described their concerns over 
receiving low pay. Three participants described supporting families abroad financially. 
One participant commented on how he felt an obligation to work rather than continue 
his education when he came to the UK from East Africa aged 18. 
Three participants identified cultural differences between their countries of origin and 
the UK, where they perceived it as strange that that people living in the UK take less 
initiative to socialise. 
“In this country, nobody have life. Everybody open the door, you go out, work, 
close the door, you go sit in your house.” (P8) 
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Ideas of HIV and TB prior to receiving diagnoses 
Perceptions of HIV and TB in countries of origin 
Four participants commented about their experiences of HIV being linked to death in 
their countries of origin:  
 
“Well, the media portrayed it as a very scary thing. […]1 Thin people, people 
lying on mattresses that are on the floor unable to move… errm, withering 
away… dying”. (P2) 
 
Three participants from Sub-Saharan Africa linked TB to poverty: 
 
“In [detail of East African country removed], quite a lot [have TB] because most 
poor people they get that because they live in tight place”. (P3) 
 
Perceptions of HIV and TB in the UK 
Five participants commented on not hearing anyone talk about HIV or TB in the UK 
prior to being tested. 
 
1 An ellipsis [...] denotes that a section of the extract has been removed to promote the 
clarity of the quote. Words placed between square brackets have been added by the 
researcher so that the extract can be easily understood.  1 
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Accessing healthcare to the point of receiving HIV and TB diagnoses  
Prior testing for HIV 
Two participants spoke about previously being tested for HIV. This happened at sexual 
health services (SHS) and they received a negative result. One female participant 
described applying for a mortgage in Southern Africa and receiving a result indicative 
of HIV. 
Experiencing delays in HIV and TB testing 
Three participants noted that they had felt unwell and visited the GP and/or hospital 
multiple times before being going on to be tested for HIV and TB: 
“I went to this hospital and the first thing they told me was, “This is not a 
problem, you have to go to your GP”. I said, I already went to my GP six times”. 
(P1; who was subsequently diagnosed with HIV and TB when he returned to his 
to seek care in his region of origin in Europe). 
 
In total, seven participants described presenting for emergency care. All patients 
recalled attending hospital as out-or inpatients and having multiple tests performed, 
which many perceived as an unpleasant experience. Two participants spoke about 
feeling frustration towards there being diagnostic uncertainty. 
 
“I kept asking “what’s going on?” and they said they still need to do more tests, 
more exams and more blood […] The worst period of my life”. (P1) 
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HIV and TB testing experiences 
Six participants spoke about consenting to have HIV tests, with two participants 
recalling presenting to emergency care so unwell that they are unsure if they were 
conscious enough for consent to be sought. One participant was not asked for consent 
when she was tested for HIV during an antenatal blood test.  Seven participants 
described not thinking about HIV when they waited for the test results. All participants 
did not anticipate that they had TB. 
Experiences whilst accessing specialist HIV and TB care 
Receiving treatment for HIV and TB 
Five participants spoke about there being a pill burden when taking HIV and TB 
medication together: 
“Errrm, oh Jesus… I start with a big cocktail in the morning – at 7 o’clock in the 
morning. It would come with a cup. I remember one time I counted and there 
were like – just in the morning – there were like 17 pills in that cup”. (P1) 
 
Six participants commented on there being medication side effects when taking HIV 
and TB medication together: 
 
“It’s like you just feel a sort of whizzing sensations on the ears […] I just felt 
unwell. Sometimes, I thought, ‘I just feel sick’. So unwell. If I’ve eaten, then I’d 
bring up food. So I just didn’t like it”. (P7) 
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Five participants commented on reasons for HIV medicine non-adherence including 
feeling “lazy” (P9) and not being a “medicine person” (P2). In addition, for one 
participant: 
 
“When I was diagnosed I was well and there was nothing wrong with me. […] 
So I left my medication for almost three years. I decided not to take it”. (P7) 
 
Three participants spoke about getting into a routine of taking HIV and TB medication. 
Four participants described the challenges of experiencing additional physical health 
conditions such as cytomegalovirus (a virus in the herpes family that can spread from 
person to person through body fluids), hepatitis, kidney disease, diabetes mellitus and 
chronic pain. 
 
Financial burden 
Four participants described their worries about how having HIV and TB had a negative 
impact on their finances due to them not working, as this put them at risk of 
eviction/homelessness. Three participants reported living in temporary/precarious 
housing after being diagnosed with HIV and TB: 
 
“I try to sleep in [detail of London station removed] for two nights!  On the third 
night, I’m sitting down in [detail of location of London takeaway restaurant 
removed] and that time I saw my friend, and then my friend tell me that, “Oh, I 
have a friend! Oh, so I will ring my friend and you can go in her house”. (P9) 
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Relationship with healthcare workers after being diagnosed with HIV and TB 
Nine participants described experiencing caring and trusting relationships with HIV and 
TB healthcare workers: 
“Same with [detail of nurse’s name removed], She was very lovely every time 
she comes, big smile, and then she’d say, “how are you?”. Oh so lovely, yeah, 
because none of my family and none of my friends come to visit me, so I was 
happy, I was happy”. (P5) 
 
Two participants spoke about feeling hope when provided with information from 
healthcare workers.  
“Yeah, they let me know, and how and why, and the treatment, how’s it going. 
Yeah, they gave me quite good information. It gave me hope”. (P3) 
 
Four participants experienced non-responsive care at times which elicited frustration 
and disappointment. 
 
“It’s like it was kind of “Oh, medication. I haven’t got much time”, then they 
would go. I wanted somebody to sort of clarify to me what was that”. (P7) 
 
Four participants spoke about how they were provided with support with entitlements to 
financial and housing assistance: 
 
“They gave me HC2 certificate [that provides full help with health costs], which 
enabled me to claim. Before that time, there was no claiming, so I had to borrow 
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money, borrow money to go to the hospital. The nurses were very, very helpful”. 
(P5) 
Managing disclosure of HIV and TB 
Disclosing HIV and TB status to others 
Seven participants described disclosing their HIV status to at least one person close to 
them and, on the whole, received reassuring responses: 
“I told him, it was like forever, and then afterwards, when I told him, at the time 
he was so – it was so instant that he just hugged me. He was shocked, and he 
just said, ‘don’t worry”. (P2) 
Three participants spoke about partners and family members being tested for HIV and 
one participant’s family members were tested for TB. One participant who was an 
inpatient found it very difficult when his partner was diagnosed with HIV and he was 
not available to be at home with him to offer him support. 
“Being in hospital and [detail of participant’s partners name removed] tried to 
discover the HIV – if he has it as well… and then he had it, and then he didn’t 
know how to get support. But, because I was not very good in my mind I 
couldn’t…because I was taking 30 pills a day”. (P1) 
Four participants spoke about preferentially disclosing that they have TB over HIV to 
friends and family, linked to TB’s perceived curability: 
“I mean, TB, everyone knows – like my family. […] I mean TB again is not 
something that I – that I thought, “Oh my God, I’ve got TB!”. There’s a cure. 
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When I got HIV, then yes, I thought like, “Oh my God, I’ve got HIV, now what 
am I going to do? I don’t want to tell”. (P4) 
 
Six participants contemplated future disclosure of HIV and many displayed concerns 
about the anticipated responses of others (e.g. blame, rejection): 
 
“And if I say this, “I have HIV, or I have this”, would they help me like that? 
They will think that you did, you deserve it, because they don’t know if I did or 
not”. (P5) 
Deciding not to disclose HIV and TB status to others 
Seven participants spoke about not wanting to disclose their HIV diagnosis for fear of 
being judged and rejected following HIV disclosure: 
 
“They say “Ohhh he is positive, don’t go close to him, don’t eat together, don’t 
do it”, maybe it give you stress. And then you feel down, and then you go split 
with your friend and everything and then you go your own way”. (P8) 
 
Three participants described deciding not to disclose their HIV or TB status as they did 
not want others to worry about them and their health. 
 
“I don’t even want to think of it because the response [from the participant’s 
mother] will not be good – on her own health, not mine”. (P6) 
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Two participants experienced breaches of confidentiality regarding their HIV status. 
Participants were shocked and upset by this. One participant had requested a letter to 
show her children’s school regarding her recovering from illness and advising that a 
relative would instead be attending her children’s school that was located abroad. 
 
“I asked for the letter for a supporting document to my children’s school because 
it’s like, I just want to get better and get back to work. The doctor said, ‘This patient 
has HIV, the viral load is such and such’. The next appointment I saw the doctor I 
said, “I didn’t expect you to be saying…” (P7) 
 
For another participant, working as an in-house carer, her employer took her to a GP 
and asked her to show the GP her medication. This doctor then disclosed her HIV status 
to her employer, who responded by ordering her to leave her job and the 
accommodation she was living in for fear that she would “infect” their children: 
 
“I give the medicine because, three times they ask me, “you are taking medicine, 
and you give me the prescription, the one you are taking, so that I will know 
what to prescribe for the cough”. The doctor told the [detail of employer 
removed] that I have HIV. […] The doctor shared… they shared. But the doctor 
do not know that I didn’t tell them that I have HIV!” (P9) 
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Managing mental health after receiving HIV and TB diagnoses 
Feelings following HIV and TB test results 
Six participants reported feeling shock and disbelief following their HIV and TB 
diagnoses: 
“I don’t believe!” I said, “no! how come that I have HIV?! […] No… errr…. I 
don’t believe, I don’t believe that I have TB!”. (P9) 
Four participants reported cognitions and worries relating to death: 
“I was worried about my daughter. I didn’t want to die”. (P3) 
All participants experienced worries and low mood after being receiving their HIV and 
TB test results. On the HADS, one participant scored in the clinical range for anxiety 
and depression, and one for anxiety only. 
One participant described how he did not disclose to his mother about his diagnoses as 
he did not want to worry her. He felt low when his mother asked him to return to West 
Africa to see her: 
“[The participant’s mother] has been telling me, “when are you coming back, 
when are you coming back? Do you want me to die before you come?”. That is 
it. So, if you go through this questionnaire [the HADS] you will see some of the 
answers there. There are things that are weighing me down”.  (P6)  
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This participant (P6) also spoke about experiencing suicidal ideation although his 
HADS scores did not meet the threshold for anxiety or depression.  
 
Another participant who scored the highest on the HADS for anxiety and depression 
attempted to take his own life when he was discharged from hospital having been an 
inpatient for three months: 
 
“I climbed the bridge there – to give up. I didn’t see nobody coming when I 
climbed, and suddenly, two lady there […] They both caught me, like, and start 
talking softly, “where you live? We come and leave you home”. They come 
home and leave me like that. I thinking what to do, then this come in my mind, 
“you are not giving up your life”. (P5) 
 
Post-HIV and TB diagnosis and stigma 
Two participants spoke about experiencing HIV related stigma from others, including a 
healthcare professional when accessing HIV and TB services. 
“Even here at this clinic. I don’t know how many [detail of healthcare profession 
removed] are infected with HIV but it’s like I just felt so much stigma, “how can 
a [detail of healthcare profession removed] be infected with HIV?”. It’s like, 
there’s so much stigma attached to it”. (P7) 
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Two participants had experiences that demonstrated an intersection between TB and 
race-related stigma. A white participant from Southern Africa spoke about disclosing 
her TB status to her mother: 
 
“And then I told her [participant’s mother] about TB, and it was like, “Oh! The 
garden boy has TB. All these blacks in this town have the TB. So you’ve got it 
as well now?” So… it hurt, it really hurt”. (P2) 
 
Accessing psychological and HIV specific support 
Two participants commented on attending HIV support organisations and found them 
beneficial: 
“Yes, yes – to learn and sort of be open to other people who have got the same. 
To sort of be in the company of people with the same problem.” (P7) 
 
Four participants identified reasons for not attending HIV support organisations, linked 
to not believing it would be emotionally beneficial to discuss their experiences with 
others. One participant indicated that he believed support groups give the impression of 
being helpful whilst only the organisers benefit.  
 
“Just normally, any supporter, they think about themselves. Not think about 
anyone. And then they ask money from somewhere and they do some small 
thing and then after that they take money, they put in their pocket and take 
camera and photos and everything about how they spent money.” (P8) 
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No participants reported attending any TB related support groups. 
Three participants had experiences of being referred to and seeing mental health 
professionals after being diagnosed with HIV and TB. Two participants saw 
psychologists who they experienced as inattentive and unhelpful: 
 
“The hospital had a psychologist come to see me. I didn’t like her […] She 
annoyed me! She was like, you know, ‘I have to spend 30 minutes with this guy, 
‘so how do you feel today?’. And I have no patience to people who don’t want 
to speak with me – just doing their job.” (P1) 
 
Appraisal and coping with HIV and TB 
Thinking about how HIV was acquired 
Four participants spoke about their confusion over how HIV was acquired and three 
participants expressed their anger towards perceived sources of their HIV infection. One 
participant made a parallel between his beliefs about the origin of HIV and how he 
acquired HIV. In both cases he appears to place the responsibility on women and spoke 
about his anger towards his wife linked to his beliefs: 
“When I was studying, it says like the HIV came from monkey. I didn’t 
understand… lady were having sex with monkey, and that lady have got that 
HIV from that monkey and she was sex with other men and that spread, like – 
same thing as that bitch my wife who gave what I have. She spread on me I 
think – I am guaranteed that”. (P5) 
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Religious beliefs/practices in the context of HIV and TB 
Many participants spoke about their religious beliefs and practices in the context of HIV 
and TB. Two participants felt despair and prayed to God for recovery: 
“I ask for healing. “Oh God, why you give it to me this one!” (P8) 
Three participants spoke about feeling protected by God and this reducing their levels of 
worry. 
“Ahh! I should have been dead by now – if I’m back home. I still know it’s the 
plan on God. Even coming here in the first place”. (P6) 
 
“Well, I was brought up in a religious way. We know that […] not all the 
problems they come to sort of punish you. Problems, they come…. your…. faith 
will be tested. You will still come out of it. It’s just a matter of time… […], you 
know. You have got faith… you’re hoping for…. Then it’s like, […] you know 
that God will help you to come out of that, whatever that… and… that’s put me 
in a position that I no longer worry about anything. I don’t worry about 
anything”. (P7) 
 
Four participants attended church and found this helpful:  
“Religion is good, and then you go church and you attend to church, like social 
life, community, everything is good”. (P8) 
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Adjusting to living with HIV and TB 
Participants commented on a number of things that linked to adjustment to HIV and TB. 
Six participants spoke about the belief that TB can be cured: 
 
“You know, to get back to normal, you treat TB. TB, when you look after 
yourself, then you take the medication, you are free". (P8) 
 
Three participants found it helpful to remind themselves of having an undetectable HIV 
viral load. All participants spoke about the positives of knowing their HIV status and 
these included limiting unknowingly passing on HIV and fast access to medical help. 
 
“Oh, knowing about it? Yeah, yeah of course! If I was not in a relationship – not 
me and [detail of name of participant’s partner removed], if I didn’t know, I 
would have passed it on to this person”. (P1) 
 
“That whenever I need healthcare, I can just make a phone call and be seen by a 
doctor – convenience”. (P4) 
Hopes for the future 
Two participants reported wanting to help others in the future who are in need. 
Participant 2 spoke in particular about feeling so strongly about helping another woman 
that she is prepared to overcome her inclination not to share with others her difficult 
experiences. 
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“I became very passionate in myself. I’d love to help one woman in my life before I 
die, who has experienced what I have and allow them just to enjoy their life, and not 
to have to go through it quietly. And I know I’m an introvert and I would rather 
keep it in than let other people realise how much it hurts”. (P2) 
 
Three participants spoke about wanting to return to work and to socialise more and to be 
in a relationship. 
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Theoretical model of the individual and social processes involved in living with 
HIV and TB co-infection for UK migrants 
The main aim of this study was to develop a theoretical model of the individual and 
social processes involved in living with HIV and TB co-infection for UK migrants. 
Figure 2 outlines how the seven theoretical codes relate to each other in an explanatory 
model of living with HIV and TB co-infection for UK migrants. The black arrows 
present the processes described by participants, as captured in the theoretical codes. For 
example, the model indicates that participants’ experiences of migration (e.g., 
experiences of multiple stressors) and ideas of HIV and TB (e.g., low risk awareness) 
impacted on them accessing healthcare prior to receiving HIV and TB diagnoses. 
Experiences whilst accessing specialist HIV and TB care and how patients managed 
disclosure decisions led to post-diagnosis phenomena such as appraisal and coping with 
HIV and TB. A bidirectional relationship is hypothesised between appraisal and coping 
with HIV and TB and managing disclosure of these. The model indicates that there are 
several processes that seem to affect how mental health is managed including: 
disclosure decisions - for example where planned (intentional) disclosure occurred, 
participants experienced reassuring responses which appeared to offer them support and 
improve their ability to cope. In addition, experiences whilst accessing specialist care - 
for example receiving support and being provided with information and updates about 
HIV and TB and their health - led participants to feel more hopeful and to cope better 
with having both diagnoses.
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Figure 2. Theoretical model of the individual and social processes involved in living with HIV and TB co-infection for UK migrants
Managing disclosure of 
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Discussion 
Overview of study findings 
This study explored the individual and social processes involved in living with HIV and 
TB co-infection in UK migrants. The study aimed to answer the following research 
question: What is the perceived impact for UK migrants living with HIV/TB co-
infection on disclosure of both conditions, relationships, help-seeking, identity and 
adjustment? 
Four participants had experienced stressful pre-migratory events (i.e., traumatic events 
such as war and threats to life, and a stressful marital split) prior to coming to the UK. 
This is in line prior research which outlines how migrants often have life experiences 
involving loss, separation from loved ones and violence (Warfa et al., 2012). In 
addition, seven participants did not have family members living in the UK and prior 
research has outlined how this can result in a lack of social support (Wilkinson & 
Marmot, 2003). 
There appeared to have been delays to testing for HIV and TB that were both patient 
and health system related. Once in the UK, many participants had not considered the 
possibility that they had HIV and TB and seven presented to emergency care with 
severe symptoms. They did not label their physical health symptoms as related to HIV 
or TB when they were tested. Low risk perception in the current sample may in part link 
to the degree of variation in sample rates of HIV and TB co-infection in participants’ 
countries of origin. For example, four of the nine participants were from countries that 
the WHO does not define as “high TB/HIV-burden countries” (i.e., high TB/HIV 
burden countries are defined as those that account for 97% of the estimated global 
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number of HIV-positive TB cases; WHO, 2015). This combined with the low incidence 
of HIV/TB co-infection in the UK (i.e., in 2017, 2.8% (139/4,924 of people with TB 
were estimated to be co-infected with HIV; PHE, 2018) may have further decreased 
awareness of the risk of having these conditions. 
The HIV and TB diagnoses often occurred after multiple tests were carried out by UK 
sexual health clinics or health professionals located in hospitals. Many tests were 
provider initiated based on symptoms (i.e., when participants presented to Accident and 
Emergency). Although no official figures exist for the broader group of UK migrants, 
previous research has found that Sub-Saharan Africans are the community most affected 
by late HIV diagnosis in the UK (Nash et al., 2018). It appears that there were barriers 
to testing and missed opportunities for HIV and TB diagnoses. GPs and other health 
professionals may be reluctant to test their patients for HIV and TB even when faced 
with someone from at at-risk group presenting with HIV and TB symptoms. Different 
recommendations exist for testing for HIV: Since 2008, The National Institute of Health 
and Care Excellence (NICE) in the UK, and BHIVA’s testing guidelines for HIV 
(BHIVA, 2008) recommend a routine offer of HIV testing to young people and adults in 
primary care settings where HIV prevalence exceeds 2 in 1000. BHIVA’s (2008) testing 
guidelines for HIV also recommends routinely offering tests for all men and women 
known to be from a country of high HIV prevalence. 
 
Only three participants spoke about previously being tested for HIV. Seven participants 
reported not thinking that they had HIV and all did not think that they had TB. This 
finding might be explained in part by the Precaution Adoption Model (Weinstein & 
Sandman, 1992). The model outlines seven stages of how a person comes to a new 
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decision, and how that person can take the decision and make it become an action. The 
stages covered are: (1) being unaware of the issue, (2) unengaged by the issues, (3) 
Deciding about acting, (4) Deciding not to act, (5) Deciding to act (6) Acting, and (7) 
Maintenance. Although most participants were aware of HIV and TB in their countries 
of origin, it appears they did not think that they would be at risk of HIV or TB. They 
reported not hearing HIV or TB spoken about in the UK and were unengaged by the 
issues prior to their test results. A decision to be tested did not therefore need to be 
made. Increased awareness and knowledge of HIV and TB in the UK may have helped 
participants to move from being stage 2 to stage 3.  
 
There may be additional behavioural and psychological factors that explain HIV and/or 
TB risk perception. A systematic review by Evangeli, Baker, Pady, Jones and Wroe 
(2016) examined the relationship between such factors and current HIV-risk perception. 
They found that the presence of symptoms perceived to be consistent with HIV was 
related to HIV-risk perception. In addition, many studies included in this review showed 
a lack of a relationship between one’s own sexual risk behaviour and risk perception 
and this may be because in some situations one’s behaviour is not appraised as an HIV-
risk behaviour, perhaps because in the past similar behaviour did not result in HIV 
infection. Risk appraisal processes may therefore mediate the relationship between risk 
behaviour and risk perception in line with the Common Sense Model (CSM; Leventhal, 
Meyer & Nerenz, 1980) of illness representations. This appraisal process may act to 
minimise anxiety about current risk. Positive associations have been found between 
perceived HIV risk and HIV testing, and between HIV knowledge and testing. 
Participants may not be aware that their behaviour may have put them at risk and not 
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gone for HIV testing which is consistent with the findings of Evangeli, Pady and Wroe 
(2016). 
 
All participants engaged well with HIV-specialist care after being diagnosed with HIV 
and TB and described good relationships with healthcare professionals at the HIV 
specialist services. The current model indicates that experiences whilst accessing 
specialist HIV and TB care helps participants manage their mental health following HIV 
and TB diagnoses. Receiving support and being provided with information and updates 
about HIV and TB and their health, led participants to feel more hopeful and to cope 
with having both diagnoses. It may be that receiving information altered participants’ 
illness perceptions around controllability/curabilty. This is in line with the Common 
Sense Model (Leventhal, Meyer & Nerenz, 1980) that proposes that illness perceptions 
can influence coping strategies. 
Participants reported feelings of anxiety and low mood following HIV and TB positive 
test results. Four participants experienced cognitions and emotional distress during TB 
treatment, that related to having a near-death experience (i.e., a traumatic stressor) when 
very unwell. A systematic review of evidence has found that in intensive care unit 
(ICU) survivors, post-traumatic stress disorder (PTSD) symptoms are common and 
negatively impact on quality of life (Davydow, Gifford, Desai, Needham, & Bienvenu, 
2008). Of note however, no current PTSD features were spoken about, and no 
participants were accessing psychological support at the time of the interview. One 
participant scored above the clinical threshold for anxiety and depression and one other 
participant for anxiety on the HADS. One of these participants expressed anger towards 
his wife as he believed that he acquired HIV from her, the other expressed helplessness 
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around her diagnosis and multiple stressors including financial difficulties. Both these 
participants had not been offered psychological support following their HIV-diagnosis. 
Three other participants had been offered psychological support. Two males from 
Europe who disengaged quickly, explaining that they felt unheard, and one female from 
Southern Africa who was unaware whether there would be follow-up beyond an initial 
session. The other participants appeared to be adjusting well in relation to mental health. 
Two participants had attended HIV support groups and reported finding it helpful 
listening to the experiences of others. The majority of participants were not found to 
have anxiety or depression at the time of the interview and this may indicate that they 
experienced time-limited adjustment difficulties that were resolved. It appears that 
many participants moved between stages proposed by the Stages of Grief model 
(Kübler-Ross, 1969) which can be a framework for understanding adjustment to 
diagnosis. Stages included strong denial, anger (with turmoil), bargaining (wish for 
illness to go away), depression (withdrawal from the world), and later acceptance of the 
diagnosis and a new life with HIV. 
Participants spoke about concerns related to being rejected and isolated should they 
disclose their HIV and TB statuses. For those participants admitted to hospital, they 
engaged in masking and concealing strategies for their HIV and TB diagnoses. Over 
time participants made the decision on whether to share or not their HIV and TB 
statuses. This is not surprising and much evidence exists around HIV-stigma (Earnshaw 
& Chaudoir, 2009). Eight participants told at least one person of their HIV status. All 
told at least one person about their TB status. All participants expressed concerns 
around disclosing their HIV-status to some groups, with some participants preferring to 
disclose that they have TB only. The model of disclosure anxiety proposed by Evangeli 
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and Wroe (2017) fits with many of the disclosure concerns that participants reported. 
This model has four components: (1) HIV core beliefs, (2) a trigger event, (3) a threat 
interpretation resulting in HIV-disclosure anxiety processes and (4) cognitive, affective, 
behavioural and physiological processes maintaining this. It is suggested that 
internalised HIV-stigma linked to negative HIV core-beliefs can predispose a person to 
disclosure anxiety. In the current study, diagnosis appears to act as a trigger event which 
led to decisions around who to disclose to, linked to perceptions of threat. Most often 
close family members were told about HIV. With regard to TB some participants shared 
only this diagnosis with a wider group of family and friends, whilst others chose not to 
share their TB diagnosis with many others. All participants who were in relationships 
that pre-dated their HIV and TB diagnoses disclosed their HIV and TB statuses to that 
person. Previous research in a low-income setting has found that a “double stigma” 
exists for HIV and TB, whereby disclosure of TB is often interpreted as the person also 
having HIV (Daftary, 2012). In the current study, this was not explicitly spoken about 
by participants, however the three participants from Sub-Saharan Africa spoke about not 
wanting to share their HIV or TB diagnoses with wider family and friends as they 
anticipated that they would experience discrimination.  The current model suggests that 
where planned disclosure (HIV and TB disclosure that is intentionally made to chosen 
others) has occurred participants have had reassuring responses. This can help 
participants cope with living with HIV and TB as support can be gained from others 
around them via disclosure. This can in turn help participants manage their mental 
health following their HIV and TB positive results. 
All participants spoke about moving towards adjusting and coping with their HIV and 
TB diagnoses and experiences. Moss-Morris’ model (2013) proposes that good 
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adjustment to chronic illness involves less distress, less interference/impact on life roles 
and relationships and good illness management. According to this, most participants 
appeared to be moving towards good adjustment. All demonstrated effective illness 
management by adhering to ART. In addition, from their descriptions, most participants 
experienced lower levels of HIV and TB related distress compared to when they were 
initially diagnosed. Five participants spoke about the importance of their religious 
beliefs in appraising and coping with their HIV and TB diagnoses. They linked this to 
feeling protected by God and that there was a plan for them. Spirituality/religion in 
PLWH has been found to improve health/quality of life directly and through mediating 
factors (active coping - healthy behaviours, optimism, social support) to help people 
cope with stressors, especially stigma/discrimination (Szaflarski, 2013). It appears that 
although participants experienced threatening primary appraisals of HIV and TB, in 
time secondary appraisals emerged indicating that the stressors were manageable. This 
is in line with Lazarus & Folkman’s transactional model of stress (1984). 
Strengths and limitations of the study 
There had been limited research into the individual and social processes of living with 
HIV and TB co-infection in a high-income country. A strength of this study, is that it 
addressed this research gap. In addition, service-user feedback was sought on the 
interview schedule prior to data collection to ensure relevancy and understandability of 
content. Peer review was provided by the internal supervisor on the initial coding table 
for sense and clarity alongside frequent supervision. The sample was diverse (e.g., from 
different countries of origin, time since diagnosis and time living in the UK) and this 
suggests that the current proposed model could apply to a wide population. The narrow 
age range of participants however, increases the internal validity of the study, but 
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decreases the transferability. This study met a number of quality criteria, for example 
situating the sample – including participants’ demographic information to aid the 
reader’s understanding of the sample and assess transferability of findings; grounding in 
examples (e.g. use of example quotes throughout the results section for each identified 
theme), Credibility checks were provided by the internal supervisor (e.g. on interview 
schedule, coding and the developing the theoretical model); Coherence - by naming the 
theoretical codes and appropriately summarising the analysis whilst attempting to 
preserve nuances in the data (for more details on this please see pp. 89 – 90). 
Limitations of the study include the sample size. The number of interviews required for 
Grounded Theory remains contested and by some it has been suggested that 12 
interviews are sufficient. Others however, believe the number needs to be higher than 
this (Charmaz, 2006). The current sample size may therefore be too small and limit 
transferability and credibility of the findings. It is also unlikely that all categories 
reached theoretical saturation however common themes did consistently emerge. 
Although theoretical sampling was aimed for, this was impacted by limitations with 
recruitment, for example recruiting mainly men to the study. Three women declined to 
participate citing worries of emotional distress, and one man declined as he was 
undergoing TB treatment and felt that being interviewed would be tiring. It is unknown 
if the four eligible others who declined to participate were different from the nine 
participants that chose to take part. It may be that the participants who agreed to be 
interviewed were experiencing better adjustment. In addition, more variation in the 
sample relating to migration status (the majority had settled status) and those who are 
still undergoing TB treatment could help improve transferability of findings. Due to 
time limitations, the Grounded Theory model was not shown to participants and it 
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would have been helpful for this to be validated by them. All the recruitment sites were 
based in London and these clinics had integrated HIV and TB care. It may be that this 
impacts on transferability of findings as the setting of other clinics may be different. 
Although all participants were proficient at speaking English, at times, it appeared that 
participants did not quite understand questions asked and some needed to be simplified. 
Use of an interpreter may have helped capture greater nuances of participants’ 
experiences, in particular, participants may have felt more confident and expanded on 
emotional responses to living with HIV and TB. At present it is difficult to ascertain 
whether this is a cultural phenomenon, a consequence of having to focus on more 
practical matters of surviving, or linked to language difficulties. In addition, only one 
service user was recruited for consultation, in part linked to limited time available for 
this. It would have been helpful to consult more service users on the interview schedule 
regarding relevance and understandability of content.  
Implications for future research and practice 
 
Implications for practice include demonstrating the negative impact delays to care have 
on UK migrants with HIV and TB co-infection (e.g., on managing mental health). Six 
participants who were told that an HIV test would be carried out actively consented to 
it. Sharing this finding with healthcare workers might help reduce any reservations they 
may have about patients’ reactions to being offered an HIV test and support early 
diagnosis. A UK report also found that primary care professionals tended to 
underestimate rates of TB within their area. A report by the Health Protection Authority 
(2010) found that in addition to requiring more information on TB diagnostic tests and 
clearer referral pathways, GPs also wanted to know more about screening for latent TB. 
Clarifications around existing guideline for testing high risk groups for HIV and TB 
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could help avoid delays and promote early diagnosis. At present, BHIVA (2019) 
advises that healthcare professionals make referrals for suspected TB to specialist 
services with experience of managing HIV/TB co-infection. To promote good patient 
centred care, current study findings could also help advise healthcare professionals on 
the information and support migrants find most helpful following HIV and TB 
diagnoses (e.g., information on medication and progress updates). The findings show 
the positive experiences of participants with HIV and TB co-infection including 
continued engagement with HIV-specialist clinics and positive and supportive 
relationships with healthcare professionals. This information could be helpful for 
individuals who are considering having an HIV test and encourage them to seek care 
earlier across settings. In addition, there were low levels of risk perception and high 
levels of stigma. It could be helpful to run an audit in services to find out the reasons 
why there is such a high level of stigma and how to respond to reduce it. Also, 
psychologists could work with professionals to create ways to raise and discuss issues 
(e.g. in reflective groups) that are linked to late testing and diagnosis of HIV and TB in 
this population. 
 
It may be that testing being routine rather than relying on professionals is helpful (e.g., 
in GP practices in areas of high prevalence). This would mean that testing is targeted 
rather than provider initiated for HIV. It is important to note that since 2008, The 
National Institute of Health and Care Excellence (NICE) in the UK, recommends a 
‘routine offer of HIV testing’ to all 15 – 59-year olds in primary care settings where 
HIV prevalence exceeds 2 in 1000. With regard to future research, participants in the 
current study were 33 years old to 63 years old. It would be useful to learn more about 
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the experiences of younger migrants in the UK living with HIV and TB co-infection and 
about what facilitates adjustment. 
 
Five participants spoke about how their religious beliefs have been helpful for them to 
cope and adjust to their HIV and TB co-infection diagnoses. It would be useful to 
conduct an audit on how many healthcare professionals in HIV services do enquire 
about religious beliefs as links could be made with religious organisations and leaders in 
the community to support patients. This is not currently promoted in BHIVA Standards 
of Care (2018). Future research could include migrants in the UK who are still on TB 
treatment and interviews with family members to learn more about disclosure decisions 
and mental health support in this population. Any work being done with family 
members of patients would require consent to share diagnoses from patients.  
 
In addition, ways to reduce stigma and risk perception in this population could include 
providing information on HIV and TB in an accessible, culturally appropriate way via 
social media and community/faith groups. Evidence indicates that education and direct 
contact with someone who has HIV can help to reduce stigma (Brown, Macintyre & 
Trujillo, 2003). Also, for healthcare workers, reflective groups around the challenges of 
asking for consent to test for HIV during an antenatal blood tests could he held. 
Reflective discussions could also occur here on taking care not to breach confidentiality 
of HIV status. This is important to note, as participants experienced breaches in 
confidentiality in the current study and for one participant this had very serious 
consequences, resulting in her losing her job and being told to leave her home. 
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To help test the model empirically, interventions could be provided and their outcomes 
monitored. For example, to support the reduction of stigma and help manage disclosure 
and mental health after receiving HIV and TB diagnoses, individual and group 
psychoeducation could be provided to patients, their family and friends. Psychological 
interventions such as motivational interviewing could help support continued HIV and 
TB treatment adherence. In addition, interventions such as Acceptance and 
Commitment Therapy and Compassion Focused Therapy can help support flexibility of 
responses to experiences of stigma and increase compassion whilst reducing shame and 
self-stigma. These interventions could be provided in culturally informed ways in 
services by psychologists working with other health professionals to support positive 
appraisals of living with HIV and TB and coping. Impact on outcomes such as 
depression and anxiety and broader quality of life measures could be monitored. Future 
work could be embedded in the Medical Research Council (MRC) Framework on 
complex interventions to develop and evaluate interventions. The MRC Framework 
(Craig et al., 2008) specifies four key stages to complex intervention development: (1) 
Development, (2) Feasibility/Piloting, (3) Evaluation, and (4) Implementation. It 
emphasises the importance of reporting findings at each stage of development. 
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4. Integration, Impact and Dissemination 
Integration 
 
I began working in an HIV field as a Trainee Clinical Psychologist in 2018. My interest 
in HIV originated from my interest in stigma, disclosure and physical and mental health 
conditions that are often “invisible”. My interest in TB developed when having 
conversations with my mother and people she knew, including a family relative, who 
had been diagnosed with TB in India and Iran. I learnt that this happened at a time and 
location when medication was not so accessible and this raised my awareness of 
international health inequalities. These experiences led me to want to learn more about 
the re-emergence of TB in the UK, in part linked to HIV and migratory phenomenon. 
Over time, I gained basic knowledge of HIV and TB and issues linked to stigma and the 
psychological impact of receiving HIV and TB diagnoses. This combined with guidance 
and support from my academic supervisor helped me to progress towards conducting 
the systematic review and empirical project. 
The systematic review and the empirical piece guided and informed each other 
throughout each research stage – including development of research questions, analysis 
and write up phases. A qualitative systematic review appeared suitable as it allowed for 
a more in-depth examination of illness experiences in those with HIV and comorbid 
physical health conditions. Quantitative research appeared unlikely to be able to capture 
this depth. It also helped me familiarise myself with qualitative research approaches 
prior to embarking on the empirical project. Both the systematic review and the 
empirical piece focused on the lived experiences of HIV positive individuals with HIV 
and comorbid physical health conditions. The systematic review focused on illness 
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experiences; and the empirical piece focused on the social and individual processes of 
living with HIV and TB co-infection. Relevant factors included HIV and TB stigma 
processes, disclosure, and adjustment, in addition to managing mental health 
difficulties. The location of participants was different across the two pieces of work. 
Participants in the systematic review were located in low- middle- and high- income 
countries. Participants in the empirical piece were from the UK – a high income setting. 
The age of participants varied, with the participants in the empirical piece aged from 33 
to 63 years. The participants in the systematic review had a larger age range from 18 to 
69 years of age.  
Both pieces of work examined the experiences of men and women. The systematic 
review and the empirical piece found themes across low-and high-income settings 
relating to HIV and comorbid physical health condition stigma, and HIV and comorbid 
physical health condition related distress – in part linked to treatment and stigma 
processes. In addition, a theme was found on the negative impact HIV and comorbid 
physical health condition diagnoses can have on mood. They both also found themes on 
disclosure decisions, and included examples of participants deciding to tell and not tell 
others about having HIV and a comorbid health condition. Examples of positive 
adjustment and challenges to adjustment were also found in both pieces of work. 
Prior to commencing research, I had a general understanding about HIV including how 
it was often transmitted through sex, and the stigma associated with being HIV-positive. 
I had less familiarity with stigma processes present around having other comorbid 
health conditions and I found it surprising to learn about research indicating a “double 
stigma” around HIV and TB in South Africa. I had thought about TB as a disease from 
the 1800s, I and remembered learning about how the poet John Keats died from 
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“consumption” (i.e., a term previously used for TB where individuals with the disease 
lost a large amount of weight) when I was at school. Until starting the current research, I 
did not realise that HIV/TB co-infection was so prevalent in Sub-Saharan Africa. 
Reading about the stigma that individuals with HIV and comorbid physical health 
conditions face, helped inform questions on the interview schedule for my empirical 
piece (e.g. asking about – HIV and TB disclosure and participants’ pre-testing 
knowledge of HIV and TB in their countries origin and/or the UK). It was interesting to 
see that this notion of “double” stigma – where TB was thought to indicate HIV 
diagnosis – was not spoken about by the participants in the empirical piece. On 
reflection, this may be in part linked to around half of participants originating from 
countries and then living in the UK where the prevalence of HIV and TB co-infection 
are not amongst the highest. HIV and TB may not therefore have been at the forefront 
of their experiences to draw on.  
Reading about some of the experiences of individuals in the systematic review literature 
helped me to realise the impact of disjointed services and a lack of financial resources 
on patient care and adjustment. In addition, listening to the financial difficulties that 
participants in the empirical piece faced was particularly shocking. For one participant, 
a doctor breached her confidentiality and disclosed to her employer than she had HIV. 
This led to her being told to leave her job as a domestic worker/carer – a place where 
she also lived. My contextual knowledge gained through the systematic review helped 
me to understand the data more and added to my thinking around the perceived impact 
of living with HIV and TB. 
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When conducting the systematic review and the empirical piece I tried to consider 
Burnham’s social graces (Burnham, 2013) and I reflected on my gender, age, ethnicity, 
education, class and religious beliefs. These factors may have influenced the degree to 
which participants did or did not feel comfortable to speak about issues during the 
interviews. It may be that being an Iranian-White female who passes as White and 
sounds as though I am from an English middle-class background influenced the 
discussions I had with participants. This influence may relate to me being in a position 
of power and participants feeling less able or comfortable to describe difficult emotional 
circumstances to me. Male participants spoke about being “fine” and at times it was 
difficult to gain information about emotional experiences from them. This also helped 
me to reflect further on being a researcher who did not speak the first language of many 
participants. I wondered about the nuances of their experiences that I may have missed 
because of this. Females who agreed to participate appeared to speak in more depth 
about their experiences and may have felt comfortable speaking to a female interviewer. 
Of note, three of the four people who approached to take part were women who cited 
the worry that being interviewed about their experiences would be too emotionally 
distressing. It would be interesting to hear more about the experiences of females to 
learn whether they have experienced particular forms of gender-linked discrimination. 
Listening to a participant speak out his ideas of how women spread HIV by having 
sexual relations with monkeys elicited feelings of confusion and frustration in me that 
my role was not an educative one. Hearing these ideas led me to again wonder further 
about gender-linked discrimination that women with HIV face. In addition, listening to 
participants speak about the intersection between TB and race-related stigma led me to 
wonder about wider experiences of structural racism that may be present for UK 
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migrants and how these issues can be responded and challenged by healthcare 
professionals and community groups. 
 
Both the systematic review and the empirical piece involved synthesising findings to 
create overarching themes. Although I tried to remain aware of potential biases, it is 
possible that my own perspectives influenced the findings. It may be the case that my 
coding was influenced by confirmation bias where I was looking to confirm my prior 
beliefs. I tried my best to adhere to quality guidelines for completing qualitative 
research and my findings were discussed with my academic supervisor. In addition, I 
reflected on ideas of “insider” and “outsider” researchers. Gair (2012) suggests that the 
notion of insider/outsider status can be “understood to mean the degree to which a 
researcher is located either within or outside a group being researched” (p. 137). I 
reflected on how in many ways I was an outsider researcher as I did not share the direct 
experiences of many of the participants. It may have been helpful to hold intimate 
knowledge of such experiences, in particular in interpreting the results of the study. Of 
interest, researchers have attempted to move past a strict “insider/outsider” dichotomy 
to emphasize that researchers fall in the “the space between” the two extremes (Dwyer 
& Buckle, 2009). It has been helpful and at times difficult to reflect on where I am 
positioned within this space to explore how my status may have affected the research 
process and its outcomes. 
Impact and dissemination 
 
Findings of this research have the potential to positively impact a number of different 
stakeholders including migrant populations living with HIV and TB co-infection in the 
UK, their family members, healthcare professionals working with this group, service 
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providers (e.g., general practices), and commissioners. In addition, findings may be 
helpful for support organisations and community/faith leaders supporting this group. 
To help disseminate results to migrant populations living with HIV and TB-co-
infection, a key summary of the findings could be provided on HIV support websites 
(e.g., the National AIDS Trust, Positively UK and Terrance Higgins Trust). Information 
could be provided on entitlement to NHS care, opportunities to test for HIV and TB in 
primary care and sexual health clinics, follow-up after HIV testing, the benefits of 
medication adherence, positive experiences with disclosure and examples of adjustment. 
This may help promote hope to individuals accessing information pre- or post- 
diagnosis of HIV/TB co-infection. Any information shared would need to be provided 
in an accessible format (e.g., simple, clear prose in a variety of languages) for 
individuals whose first language may not be English. Although all participants in the 
sample were selected to meet the selection criterion of English language proficiency, 
there may be others who are not proficient and would benefit from this. Participants of 
the study will be provided with a short summary in lay language to inform them of the 
study results. This summary can also be provided to healthcare professionals to give to 
individuals following HIV and TB testing in a range of settings including primary care, 
sexual health clinics and hospitals. This has the potential to support them to feel 
increased hope and confidence and to promote engagement with services. Friends and 
family members of individuals with HIV/TB co-infection could also be provided with 
study findings around positive disclosure experiences to increase their awareness of the 
challenges these individuals may be facing and how best to support them.   
To support early diagnosis and support for individuals with HIV/TB co-infection, a 
factsheet with key findings can be provided to the Royal College of General 
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Practitioners (RCGP), alongside individual GP practices in high HIV and TB 
prevalence areas. Information could be provided on UK BHIVA guidelines for testing 
for HIV and TB; guidelines around differential diagnoses; the impact of delayed HIV 
and TB diagnoses on migrants to the UK; information migrants may find helpful 
following positive HIV and TB test results (e.g., benefits of taking medication 
consistently, and impact on life expectancy); and maintaining good 
relationships/support between patients and specialist services. A summary of the 
findings could be disseminated to PULSE (i.e., a website for GP news, including 
information on clinical, political, commissioning and practice). GPs may find that 
learning about patients’ experiences helps them to feel better equipped to offer HIV and 
TB testing/refer onwards for TB testing at specialist services. In addition, training could 
be organised between GPs and other healthcare professionals working in sexual health 
services (SHS). This could help strengthen links between local HIV-services and GP 
surgeries to support earlier diagnoses of HIV and TB. 
Healthcare professionals working in HIV services could benefit from the research 
findings. I aim to present the study’s findings to healthcare professionals at team 
meetings. These professionals include HIV doctors, health advisors, nurses, clinical and 
counselling psychologists. They may find it helpful to learn about the experiences of 
migrants in the UK, testing across services (e.g., SHS, Accident and Emergency). 
Raising awareness on this may help professionals support and work clinically with this 
population. The study highlighted that some participants experience distress from the 
pill burden and side effects of taking HIV and TB medication. Having conversations 
and reflective practice in this setting may support clinicians to remain aware of these 
challenges for patients. Clinicians can gain ideas of how to speak with patients about 
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challenges and barriers linked to medication intake. It could also help clinicians learn 
that the support they are providing around informing patients about medication is 
perceived as helpful by a migrant population with HIV and TB. The findings of the 
empirical piece will be submitted to an academic journal such as AIDS Care. The 
research will also be presented at conferences (e.g., the AIDS Impact conference). The 
aim of this is to make the research findings accessible to clinicians and academics 
working in the HIV and TB field and raise awareness about suggestions for future 
research. 
Research has found that religion serves important roles in coping, survival and 
maintaining overall wellbeing within HIV-positive migrant communities and can 
influence physical and mental health (Arrey, Bilson, Lacor & Deschepper, 2016). 
According to the BASSLine survey (Dodds et al., 2008) of HIV-positive Africans in 
England, over 70% of black Africans are Christian and just under 20% are Muslim, 
while only 6% report having no religion. Five participants in the current research 
reported that they were religious and that their beliefs had been very helpful in adjusting 
to living with HIV and TB. Faith leaders can help to promote HIV and TB awareness, 
along with providing clergy with information about HIV and TB prevention and 
treatment. It may be helpful for faith leaders and institutions to have their support for 
migrants living with HIV and TB acknowledged. This could help increase their 
confidence in supporting this population. To help disseminate findings, a working group 
could be organised where key stakeholders are invited. These could include faith leaders 
from high HIV/TB prevalence communities, representatives from HIV support 
organisations, migrants with experiences of living with HIV/TB co-infection and 
healthcare professionals. Relationships between these organisations and individuals can 
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be fostered and further strengthened. This can also help with the promotion of health 
services amongst these communities with the aim of supporting the reduction of stigma 
of having HIV and TB.  
Participants reported feeling more hope when updated by healthcare professionals about 
the positive effects of medication and when they were updated on their progress. To 
promote this on a largescale with ease of accessibility for patients, social media pages 
could be generated.  This could be done by people who have experiences of living with 
HIV and TB. Evidence from HIV campaigns has shown that testimonials from PLWH 
are helpful in removing and correcting misinformation. Evidence indicates that this can 
support empathic understanding which reduces stigma (Brown et al., 2003). 
Testimonials could be provided in the form of mobile phone apps, access to videos that 
contain interviews with migrants with HIV and TB experiences. Given the concerns 
around confidentiality found in this population, it may be that an online forum can be 
set up with anonymous participation in a variety of languages. In addition, in a 
qualitative systematic review of the experiences of peer support workers (PSW) in 
health (including those with HIV), PSW experienced feelings of belonging and 
reframing of the past to provide meaning to experiences of suffering. It also found that 
it enhanced an awareness of their ability to participate and ‘give back’ to others 
(MacLellan, Surey, Abubakar & Stagg, 2015). 
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Appendices 
Appendix A:  Interview Schedule – Adjustment in UK Migrants with HIV and TB 
 
1 I’d like to learn what life like is for you… 
Prompts: Tell me about your background: 
Origins: Where do you come from?  
Current: Where do you live?  
Family: Who is in your family?  
Employment: What do you do for a living? 
Arrival in UK: When did you come to the UK? What was it like coming to the 
UK?  
Living in UK: What is it like living in the UK? 
Learning English: Did you have to learn English when you came to the UK? 
How has it been learning a new language?  
Immigration status: What was your immigration status when you were first 
diagnosed with HIV and TB and what is it now? If relevant – what has it been 
like having an uncertain immigration status? 
2 I’d like to learn about your experiences of HIV and TB before being tested 
for either condition… 
Where were you tested for HIV and TB? 
Before being tested: 
What were your experiences of HIV and TB in your country of birth?  
What were your experiences of HIV and TB in the UK  
Did you know anyone with either HIV or TB? 
3 I’d like to learn how you came to be tested for… 
HIV 
TB 
Prompts: 
 
a. First diagnosis: I’d like to ask you  - which condition you were diagnosed 
with first: 
When: When was that?  
Where: Where did this happen? how was that?  
Tests: What kind of test/s did you have – blood test or scan? How was that? 
Knowledge of being tested: Did you know you were being tested for HIV and 
TB? If you did know, how was this explained to you?  
Whose idea was it to get tested for HIV and TB? 
Did you think you might be HIV positive/have TB? How did you feel about 
testing for these? 
Waiting for results: What was it like waiting for the results of HIV and TB 
tests? 
 
b.Second diagnosis: I’d like to ask you - which condition you were diagnosed 
with second: 
When: When was that?  
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Where: Where did this happen? how was that?  
Tests: What kind of test/s did you have – blood test or scan? How was that? 
Knowledge of being tested: Did you know you were being tested for HIV and 
TB? If you did know, how was this explained to you?  
Whose idea was it to get tested for HIV and TB? 
Did you think you might be HIV positive/have TB? How did you feel about 
testing for these? 
Waiting for results: What was it like waiting for the results of HIV and TB 
tests? 
4 I’d like to know what your experiences were after finding out the positive 
result … 
HIV 
TB 
HIV/TB together 
Prompts: 
Current treatment: Are you still receiving treatment for HIV and TB? How is 
that going?  
Previous treatment: If you have previously had TB, what does it feel like to have 
gone through treatment? For both at the same time? 
Did you know anyone who had HIV and TB in your country of birth and/or the 
UK? How did that influence you? 
Do you know anyone who has been treated in your country of birth and/or the 
UK? What are your thoughts on that? 
5 I’d like to learn more about your attendance at the HIV clinic and a TB 
clinic… 
Prompts:  
Attending HIV and TB clinics: What have been your experiences of attending 
HIV and TB clinics? 
HIV and TB clinics distance: Were the clinics near one another? How was this 
for you? Helpful? 
If you have had experience of attending HIV and TB clinics abroad, how did it 
compare to your experience in the UK? 
Current attendance: Are you still attending? How long have you been 
attending/did you attend for? 
Have you always attended the same clinics or have you changed for any reason? 
What was it like starting medication for HIV and TB? How has it been 
consistently taking medication? 
Have you had any contact with support organisations for either HIV or TB? 
How has that been? What was difficult about this? What made it easier for you 
to attend? 
6 What was your relationship like with healthcare professionals before you 
were diagnosed with….? 
a. HIV  
b. TB 
Prompts:  
How did healthcare professionals share your diagnoses with you? How was that 
experience abroad and/or in the UK? 
Tell me how your relationship with healthcare professionals developed after 
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being tested abroad and/or in the UK? 
What was your relationship like with healthcare professionals whilst attending 
HIV and TB clinics (abroad and/or UK)? Have you felt able to trust them, and 
that they were knowledgeable? How helpful were they? 
Have you been seen by any other healthcare professionals since being given 
your diagnoses abroad and/or in the UK? (e.g. psychologist) How has that been? 
7 Tell me who you have told about being HIV positive and/or being 
diagnosed with TB? 
Prompts: 
(If disclosed) can you tell me a bit about what that was like; what has been the 
response of others (abroad and/or in the UK)? What were your reasons for 
disclosure?  
(if not disclosed) what has prevented you from telling people?, e.g., not feeling 
the need, not wanting to, not having the confidence to). 
Future disclosure: Do you intend to disclose to anyone in the future? e.g. 
partner, children, parents, siblings, friends, colleagues? Why might that be? 
Anticipated responses to disclosure: How do you think people will respond if 
they knew – good or bad responses? What fears might others have if they knew? 
8 Can you tell me about your relationships with other people in your life 
(abroad/and or in the UK) at the moment and how they may have changed 
since the diagnoses? How have people responded?  
Prompts: 
Family 
Friends 
Sexual partners 
Employers 
What has happened? How do you feel about yourself? 
9 How have you felt about having diagnoses of: 
HIV  
TB 
HIV/TB together 
 
What has it been like knowing that you have HIV and (had) TB (and both)? – 
what was the impact?  What is it like now? 
How has it been maintaining doing things you like doing? How has it been to 
maintain your activity levels? 
How has it been handling any problems arising linked to the illnesses?  
Has there been anything that has helped you cope? E.g. talking to others, others 
may find themselves drinking or taking substances, other people like not to 
think about it. Has this impacted on your life? If what ways? 
How have you felt about socialising and relationships (friendships and sexual 
relationships)? 
What have been your experiences linked to employment; migration status; 
housing? 
Have you experienced feelings of acceptance/hopelessness? Can you tell me 
more? 
What are the benefits and negatives of knowing HIV and TB status? 
What are your feelings about the future? E.g.  For work, friendships, 
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relationships? Disclosing to others? 
Appendix B: Demographic questionnaire 
 
Date:  
 
1. What is your gender? 
 Male 
 Female 
 Other (specify) ________________________________ 
 
 
2. What is your date of birth? 
Day/Month/Year  ___________________________________ 
3. What is your country of birth? ___________________________________ 
 
4. When did you come to the UK? ___________________________________ 
 
5. What is your immigration status? 
 UK National 
 EEA National 
 Discretionary leave to remain 
 Indefinite leave to remain 
 Study or work visa(s) 
 Husband/Wife sponsorship 
 Asylum seeker awaiting decision or a Refugee or under Humanitarian Protection 
6. What is your ethnic group? 
 White 
 Mixed / multiple ethnic groups 
 Asian / Asian British 
 Black / African / Caribbean / Black British 
 Other ethnic group 
 
7. What is your main language? 
 English 
 Other, write in (including British Sign Language) 
____________________________ 
 
8. What is your religion? 
 No religion 
 Christian (including Church of England, Catholic, Protestant and all other 
Christian denominations) 
 Buddhist 
 Hindu 
 Jewish 
 Muslim 
 Sikh 
158 
 
 
 
 Any other religion, write in  ______________________________ 
 
9. Which of these qualifications do you have? 
 No qualifications 
 O’ Levels/GCSEs or Equivalent 
 AS- Levels or A’ Levels or Equivalent 
 Vocational Qualifications 
 Undergraduate Degree (for example BA, BSc) 
 Postgraduate Diploma or Degree (for example MA, PhD, PGCE) 
 
10. Last week, were you: 
 Employed or Self-employed? 
 Away from work ill, on maternity leave, on holiday or temporarily laid off? 
 Retired (whether receiving a pension or not)? 
 Student? 
 Other 
 
11. Are you currently in a romantic relationship? 
 No, I’m single 
 Yes, I’m in a romantic relationship 
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Appendix C: HIV and TB Medical Information 
 
Date:  
 
 
Date of HIV diagnosis: 
 _________________________________________ 
Current HIV viral Load:  
 _________________________________________ 
Current CD4 cell count: 
 _________________________________________ 
HIV Treatment regimen: 
 _________________________________________ 
Is HIV treatment ongoing?:      Yes  
    No 
 
 
Date of TB diagnosis: 
 _________________________________________ 
TB status:       Active 
    Latent 
    Cured 
 
Start date of TB treatment: 
 _________________________________________ 
TB Treatment regimen: 
 _________________________________________ 
Duration of TB treatment: 
 _________________________________________ 
 
Is TB treatment ongoing?:     Yes  
    No 
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Any previous or current co-morbid diagnoses (i.e. physical health conditions)  
 
______________________________________________________________________ 
 
______________________________________________________________________ 
 
______________________________________________________________________ 
 
______________________________________________________________________ 
 
______________________________________________________________________ 
 
 
Any additional medications currently being taken? ________________________ 
 
______________________________________________________________________ 
 
______________________________________________________________________  
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Appendix D: Participant information sheet 
 
  
 
Adjustment in UK Migrants with HIV and TB Co-infection 
Participant Information Sheet 
You have been asked to participate in a study about adjustment in individuals with 
HIV and TB co-infection, which is being carried out by Yvonne Whelan, a Trainee 
Clinical Psychologist, in collaboration with --------- Hospital 
  
Thank you for your interest in the research study. Please read this information sheet 
carefully. If you want to discuss the study with a member of clinic staff or someone 
close to you before making a decision about taking part, please feel free to do so. You 
can also ask Yvonne any questions you might have about the study. 
 
What is the study about? 
The aim is to explore the experiences of foreign born individuals who have been 
diagnosed with both HIV and TB.  
 
Worldwide, many people with TB have an HIV diagnosis. In the last two decades, TB 
has re-emerged in the UK, in part linked to HIV infection. At present, little is known 
about the experiences of individuals who are foreign born living with HIV/TB co-
infection in the UK. We hope our findings will help clinicians to provide better care for 
people who have HIV/TB co-infection. 
 
Why am I being asked to take part in the study? 
You have been approached to participate because you have been diagnosed with HIV 
and TB and you attend the clinic where the study is taking place. To participate in this 
study, you must have: 
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1) Been diagnosed with HIV at least 3 months ago 
2) Been diagnosed with latent or active TB at least 3 months ago and within the 
last 5 years.  
3) Been born abroad 
 
What will the study involve? 
You will be asked interview questions about your experiences of living with HIV and 
TB. You will also be asked some background questions about yourself (e.g. your age, 
gender, birthplace, length of time in the UK, immigration status, employment status and 
relationship status), and an additional brief questionnaire on mood. The interview will 
take place in a private room at the clinic you attend. If there is no space at the clinic, a 
room at Bedford Square, London (Royal Holloway Campus site) may be available. You 
can be interviewed on a clinic day or different day. The interview and questionnaire 
should take no longer than 1 hour 15 mins to complete in total. With your consent, the 
interview will be audio recorded to make sure no important information is missed. 
 
The researcher, Yvonne, will also require access to your medical details and this will be 
limited to information on: the date of your HIV and TB diagnoses, your TB status 
(including whether active, latent TB or cured), your CD4 cell count, viral load, when 
you started treatment, your treatment regimen and whether it is ongoing. 
 
What are the risks of taking part?  
We do not think there are any particular risks associated with taking part in the research. 
However, if you feel worried or distressed during the study please feel free to let the 
researcher know. You will be able to access support from the clinic you attend (i.e., -----
-- Hospital) if required.  
 
What are the benefits of taking part? 
One potential benefit of taking part in this research is that you may find it helpful to 
reflect on your experiences of having HIV and TB co-infection. You may also find it a 
positive experience to know that you are informing research which would go on to help 
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other people with HIV and TB. This knowledge could help to develop better health 
services for people in your situation. 
 
Will I get paid for taking part? 
We will reimburse your time for taking part in the study (£10 in a high street voucher). 
If you decide to attend an interview on a different day to your routine clinic 
appointment, you will also be reimbursed for travel expenses. 
 
Is my personal information kept confidential? 
Your information and responses will be kept completely confidential unless you tell us 
something that indicates you are at risk of harm. There are a few other situations where 
there may be a legal obligation to disclose information outside of your healthcare team - 
for example, if there is a risk of harm to someone else. These situations are extremely 
uncommon and we would discuss this with you before telling anyone else. Otherwise, 
your healthcare team and the researcher will make sure that your personal information 
remains private. 
 
You will be assigned a unique number to identify you throughout the study. All data 
will be stored in a password-protected database that only the research team will have 
access to. The research team includes: Yvonne Whelan, (Trainee Clinical 
Psychologist, Royal Holloway University of London - RHUL), Dr Michael Evangeli 
(Reader at Royal Holloway, University of London and Dr Stuart Gibson (Clinical 
Psychologist at ----------- Hospital). 
 
Dr Michael Evangeli will store the signed consent forms. These will be kept separately 
from anonymised participant data and will be stored for two years for audit and research 
governance monitoring before being destroyed. A separate USB associating the ID 
number with the participants’ names will be stored apart from the data and destroyed 
once it is no longer necessary to contact participants or obtain further information about 
them (e.g., once a journal article is published, up to two years after the study has ended). 
This file will have its own password. 
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The audio recording will be stored securely as a password-protected file on an 
encrypted USB. Once the interview has been transcribed it will be stored using an 
anonymous identification number and the recording will be deleted. Anonymous 
quotations from the interviews may be used in the reports for this study with all 
identifying information removed. 
 
We will ask you to provide an email address to be sent a summary of the study findings. 
This is optional. If you choose to provide this information, your email addresses will be 
stored in a separate password-protected database from your responses; there will be no 
direct association between your email addresses and your responses.  
 
What will happen to the results of the study? 
The research will be submitted in partial fulfilment of a doctorate degree in Clinical 
Psychology. We aim to publish its results in a peer-reviewed journal and at conferences. 
The published data will be anonymised and no participants will be identified. If you 
would like, we will send you a summary of the findings via the email address you 
provide.  
 
Who is organising and funding the research? 
 
The research is being led by Yvonne Whelan and is being funded by Royal Holloway, 
University of London (RHUL), as part of the doctorate programme in Clinical 
Psychology.  This study has been reviewed and approved in accordance with an NHS 
ethics committee as well as the College Ethics Committee at RHUL. 
 
Who should you contact with questions?  
This project is supervised by Dr Michael Evangeli (Clinical Psychologist and Reader 
at Royal Holloway University London) and Dr Stuart Gibson (Clinical 
Psychologist at the ---------- Hospital). 
The main person to contact for this project is Yvonne Whelan, Trainee Clinical 
Psychologist as the Department of Clinical Psychology, Royal Holloway University of 
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London (RHUL). You can get in touch in the following ways if you have any questions 
about the research at any time. 
• Email:  -------------   
• Phone: ----------- (this is an answering message service -  please say your 
message is for Yvonne Whelan, leave a message clearly stating your name and 
phone number.) 
 
Who should you contact with a complaint? 
If you have any complaints about this research or how it is conducted please contact the 
Patient Advice and Liaison Service (PALS) who can offer confidential advice, support 
and information:   
----------- participants please contact the -------------- Healthcare PALS on: -------------- 
or email ------------ 
 
What happens next? 
If you are interested in taking part, you will be given the opportunity to meet with 
Yvonne on the same day as your clinic appointment (if she is available on the site) to 
discuss whether you wish to take part in the study. If you do, you will be given the 
option to be interviewed that day, or to attend at a date and time more convenient to 
you.  
If Yvonne is not available on the site on the day of your clinic appointment, you can 
contact her on the details provided above. 
Thank you very much for taking the time to read the information sheet. If you are 
happy to participate, please complete the consent form on the next page (This will 
be shown to you in person). 
  
166 
 
 
 
Appendix E:  Consent form for participants 
 
 
 
Consent form - For Participants 
Project Title: Psychological Adjustment in UK Migrants with HIV and TB Co-
infection 
Name of researcher: Yvonne Whelan (Y.Whelan@nhs.net) 
You have been asked to participate in a study about psychological adjustment to 
HIV and TB co-infection in UK migrants, which is being carried out by Yvonne 
Whelan, trainee clinical psychologist at Royal Holloway University of London, in 
collaboration with ------ Hospital clinic.  
 
Have you (please initial): 
 
 Yes No Not 
Applicable 
Read and understood the information sheet about the above study? 
 
   
Had the opportunity to ask questions? 
 
   
Got satisfactory answers to your questions? 
 
   
Understood that participation is voluntary and you are free to 
withdraw from the study at any time? (without giving reason and 
without it affecting your care) 
 
   
167 
 
 
 
Understood that the researcher (who is outside the direct healthcare 
team) will require access to your medical details such as the date of 
your HIV and TB diagnoses, your CD4 cell count, when you started 
treatment, your treatment regime and whether it is ongoing. 
   
Understood that your information will be kept confidential 
throughout the research process, unless you tell us something that 
indicates you or someone else is at risk of harm. (We would discuss 
this with you before telling anyone else.)  
   
Understood that as part of the study your interview will be 
audiotaped and transcribed. The tape will be destroyed once 
transcribed. 
   
 
Do you agree to take part in the study? (please initial) 
Yes  
No  
 
Participant Signature:   __________________ Date:
 ___________ 
 
Participant please print name here:   __________________ Date:
 ___________ 
 
Researcher Signature:  __________________ Date: ___________ 
When complete, two photocopies to be made: 1 copy for participant; 1 copy for 
researcher and 1 (original) to be kept in medical notes. 
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Appendix F:  Payment Receipt 
 
 
 
Title of project 
 
Receipt of Payment 
 
I confirm I have received a payment of £_________ for participating in the above 
research study, conducted by Yvonne Whelan, Trainee Clinical Psychologist, Doctorate 
in Clinical Psychology, Royal Holloway University of London 
 
No.  Date Name Amount Signature 
     
 
Trainee Signature …………………………………………………. 
Supervisor Signature ………………………………………………….. 
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Appendix G:  Example of transcript with initial and focused codes 
Transcription Initial Codes Focused Codes 
I: Just to clarify, when were 
you diagnosed with HIV? 
  
P1: last year.   
I: And then was it around the 
same time that you had TB? 
  
P1: Yes, everything at the 
same time – so, I was just 
feeling like I didn’t want to 
eat, I was losing weight. I 
mean, I went six times to the 
hospital in here. They just kept 
telling me that I had gastric 
issues, and then I was not 
feeling okay, and then one day 
I went to work and I barely 
could work, and then I spoke 
with my mum, and she said, 
you’re flying to today home, 
and then I fly home on the 
same day, and then I went next 
day to the hospital. They kept 
saying the same thing, and 
then my mum said, “no you’re 
going to come with me”, so I 
went to my mum’s place, they 
give me multiple exams, they 
said, “there’s nothing wrong 
with you, but we do need to 
see what it is”. They needed to 
do more exams and then when 
I was waiting for it, I felt bad 
again and then I went to the 
hospital. 
Feeling unwell and 
visiting the GP and 
hospital multiple times 
 
Presenting for emergency 
care 
 
Having multiple medical 
tests in hospital 
 
Experiencing delays in 
HIV and TB testing 
 
I: How were you feeling bad, 
in what way?  
  
P1: Vomiting, I didn’t have 
any appetite, losing a lot – 
weight loss, no strength, no 
power for anything… and then 
the day that I went and they 
discover, my doctor asked me 
to open my mouth, and then he 
saw my tongue and he said – I 
don’t know if it’s the same 
thing here as in [detail of 
Consenting to having an 
HIV test 
 
HIV and TB Testing  
experiences 
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European country removed], 
they have to ask you if they 
can give you an HIV test? 
I: So they asked you 
beforehand? 
  
P1: He asked me, yeah if he 
could do it and I said “oh sure 
no problem”, and then he did 
it. 
Consenting to having an 
HIV test 
 
HIV and TB Testing  
experiences 
I: So how was it explained to 
you that you were going to be 
tested for HIV, did they sort of 
talk you through... or…? 
  
P1: I think it was like just a 
normal conversation. I think I 
was inside with him, and he 
asked me what was going on 
with me, and then he started to 
check me – my eyes, ears, 
tongue, and then, we were 
talking and he told “I want to 
do some exams – urine, blood 
tests, and I would like to add 
the HIV one as well”. It was 
like a very casual conversation. 
Being told that he would 
receive multiple tests 
including HIV 
HIV and TB Testing  
experiences 
I: Okay, it sounds like it was 
the doctor’s idea for you to be 
tested… for having HIV… 
And I’m just wondering if you 
thought at the time – if you had 
any thoughts about whether 
you were HIV positive?  
  
P1: No, because I went… so, 
this was November 2016, I did 
the test. I went to an STD 
clinic, and they would call me 
if everything – if anything was 
wrong. No-one called me, so… 
I wasn’t restless? I think 
everything was fine. 
Not thinking about HIV 
or TB 
HIV and TB Testing  
experiences 
 
I: So were you still wondering 
if you were, or did it put your 
mind at ease? 
  
P1: In November? No, I just 
did like a random test, just to 
see. 
  
I: Okay, and when you didn’t 
hear anything back you 
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thought –  
P1: Everything is fine. So I 
kept living my life, and not 
think about the subject. 
Believing he had received 
negative prior HIV test 
results  
 
Not thinking about HIV 
or TB 
Prior testing for HIV 
 
 
 
HIV and TB Testing  
experiences 
I: Okay, and then in terms of 
the later test – it sounds like 
you had it in [detail of 
European country removed] in 
hospital – was it linked to 
[detail removed] 
  
P1: No, it was a public 
hospital, and I just felt really 
bad on that day, and my mum 
said let’s go to the hospital, 
you have high fever, let’s go. 
Presenting for emergency 
care 
 
Experiencing delays in 
HIV and TB testing 
 
I: Okay, so when the doctor 
said, I’m going to suggest 
testing for HIV how did you 
feel about being tested? 
  
P1: Yeah, I was fine. 
Something was wrong with 
me, they had to know what 
was going on. 
Consenting to having an 
HIV test 
HIV and TB Testing  
experiences 
I: And then in terms of waiting 
for the results, what was it like 
waiting? 
  
P1: I was not expecting – that 
it was just one more day in the 
hospital without them knowing 
what was going on. It was just 
– they were going to tell me 
that I had a gastric issue again 
– that’s what I thought. 
Not thinking about HIV 
or TB 
HIV and TB Testing  
experiences  
I: And then, thinking a bit 
more about after being tested, 
finding out the positive result 
for HIV, did you also find out 
about the TB at that time? 
  
P1: No.   
I: No? Okay… So when did 
you find out about the TB? 
  
P1: So after the doctor told me 
I was positive, he told me to go 
in two or three days to an 
appointment. To another 
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doctor – infectious and 
contagious diseases – so we 
had an appointment for a 
doctor who takes care of this, 
and then he checked me, and 
he told me, “you’re not leaving 
the hospital”. 
I: Did you know at that time 
that you were being tested for 
TB?  
  
P1: No! So it was basically it 
was like a – you just – he just 
note my symptoms – again – 
tongue, eyes, and then checked 
my legs, checked my neck 
behind, to see if he find 
anything, and then, yeah, he 
told me, you’re not leaving the 
hospital. You’re going from 
here upstairs to a room. 
Feeling frustrated at the 
diagnostic uncertainty 
Experiencing delays in 
HIV and TB testing 
 
I: And then, how long was that 
gap between being tested for 
HIV and TB? 
  
P1: I don’t want to lie, but I 
would say between 3 weeks 
and a month, because the 
doctor that I had – they didn’t 
know what was going on. So 
they only discovered about 
CMV two weeks after I’d been 
in the hospital. I kept asking 
“what’s going on?” and they 
said they still need to do more 
tests, more exams and more 
blood. 
Having multiple medical 
tests in hospital 
 
Experiencing delays in 
HIV and TB testing 
 
I: What was that like?   
P1: The worst period of my 
life. 
Experiencing extreme 
worry and low mood 
Feelings following HIV 
and TB test results 
I: In what way?   
P1: All the exams, they were 
like, painful – colonoscopies, 
endoscopies, put tubes inside 
of my nose to get some liquid 
from my lungs. The fact that I 
had – they were taking blood 
constantly, so my arms start to 
get sore. Then after that came 
the medication and I couldn’t 
Having multiple painful 
medical tests in hospital 
 
Experiencing worries and 
low mood 
 
Experiencing delays in 
HIV and TB testing 
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sleep, so I had a lot of anxiety 
crisis. 
I: You experienced 
anxiety….? 
Experiencing worries and 
low mood 
 
Feelings following HIV 
and TB test results 
P1: Yes, because of the stress 
that I had was so hard that… I 
stopped seeing from my right 
eye. I don’t know how to say it 
in English, but a blocked 
nerve, and there was a point 
they sedate me so much – I 
don’t remember. 
Experiencing worries and 
low mood 
 
Feelings following HIV 
and TB test results 
I: Okay, so there’s a period 
you don’t remember so well… 
  
P1: It stopped because my 
mum came to see me, and she 
was like, “this is too much 
sedatives. I’m not having this”. 
So she spoke to the doctor, to 
reduce it because I was having 
too much. 
Reflecting on his mother 
telling the doctors to give 
him a lower dose of 
sedatives because the 
dosage was too high. 
Receiving treatment for 
HIV and TB 
I: And what was that like then, 
when it was reduced? 
  
P1: It was still really bad. I 
think it was the most of – 
mixed of emotions. I had to 
deal with the fact that I had it, I 
had to hide it, being in hospital 
and [detail of participant’s 
partners name removed] tried 
to discover the HIV – if he has 
it as well… and then he had it, 
and then he didn’t know how 
to get support. But, because I 
was not very good in my mind 
I couldn’t…because I was 
taking 30 pills a day… 
Experiencing worries and 
low mood 
 
Feeling distressed by the 
pill burden  
 
Feelings following HIV 
and TB test results 
Receiving treatment for 
HIV and TB 
I: Okay, so lots and lots of 
medication 
  
P1: We discovered after – 
[detail of participant’s 
partner’s name removed] told 
me there was four days you, 
“called me more or less the 
same time and said exactly the 
same thing every time you 
called me!” 
Feeling distressed by 
medication side effects - 
frequently phoned up 
partner an repeating 
Receiving treatment for 
HIV and TB 
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himself. 
 
I: What was it that you were 
telling him about?  
  
P1: He was telling me 
something that I was speaking 
with him about my brother. It 
happens sometimes. 
  
I: Okay, so it was a period that 
you were on quite a lot of 
medication and were anxious 
as well? You had some worries 
going through your mind? 
  
P1: Yeah, so I had my things 
in here, I had the room in here, 
I had to pay bills, and I wasn’t 
working. I had money 
together, but not enough for 
living five months in London 
and not working. 
Not working and the 
financial impact of being 
unwell  
Financial burden 
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Appendix H: Example memo 
 
09/11/2018 
Participants so far have spoken about not wanting to disclose HIV. I was surprised at 
such delays to be diagnosed with HIV and TB. They each had multiple tests. Different 
levels of comfort around sharing TB status. A participant from Europe spoke of not 
wanting to share TB beyond close friends, whilst participant from Southern Africa was 
happy to share TB with friends and colleagues. Belief that TB is just an illness. 
Participants anticipate stigma and don’t want others to respond differently to them. 
22/12/2018 
Themes of delayed access to HIV and TB diagnosis and treatment. Participant spoke 
about anger towards his wife and depression and suicide attempts – this is different 
from others experiences so far – I wonder why?. It is interesting to note that he had not 
been offered access to psychological support. Themes of religion are emerging. 
Participants have the sense that that God has a plan for participants lives providing hope 
and meaning. Both participants speaking about God have been men, although from 
different regions – [detail of South Asian country removed] and SSA. It would be 
interesting to see if religion has provided comfort to others. Financial difficulties and 
housing issues have surfaced and appear particularly stressful. 
05/03/2019 
Participants have again spoken about the importance of religion and that there is a plan 
for their lives.  Precarious housing and worrying about going into arrears a stressful 
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experience. Once again appreciating the support from hospital staff to gains stable 
accommodation.  
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Appendix I: NHS ethics approval 
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Appendix J: Royal Holloway University Ethics approval (July) 
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